Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | P5 - Poster Session 5

Monday 04/24/23
11:45 AM - 12:45 PM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Sleep, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Health Care Disparities, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
11:45 AM - 12:45 PM EST Abstract 9-001 - Is Thalamic DBS Synergistic With VNS in Drug Resistant Genetic Generalized Epilepsy?
Aafreen Khan, MD
11:45 AM - 12:45 PM EST Abstract 9-002 - Efficacy and Quality of Life Outcome of Combined Epilepsy Surgery with RNS Placement
Jie Pan, MD
11:45 AM - 12:45 PM EST Abstract 9-003 - Thalamic neuromodulation outcomes in drug-resistant refractory epilepsy with Deep Brain Stimulation and Responsive Neurostimulation
Rohit Das, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 9-004 - Clinical Outcomes in Combined Epilepsy Surgery and Responsive Neurostimulation
Anna Zolyan, MD
11:45 AM - 12:45 PM EST Abstract 9-005 - Responsive neurostimulation device use in patients with epilepsy and psychogenic non-epileptic events. Case report and Healthcare expenditure analysis related to neuromodulation therapy in Epilepsy patients
Ahmad Sawalha, MD
11:45 AM - 12:45 PM EST Abstract 9-006 - Scheduled Programming of VNS Therapy Reduces Time-To-Dose and Office Visits in the COVID-19 Pandemic
Maxine Dibue-Adjei, PhD
11:45 AM - 12:45 PM EST Abstract 9-007 - High Frequency Stimulation of the Centromedian Thalamic Nucleus to Abort Seizures and Interictal Discharges During Stereoelectroencephalography Evaluation
Cody Louis Nathan, MD
11:45 AM - 12:45 PM EST Abstract 9-008 - Ictal Thalamic Recordings in Patients with Deep Brain Stimulation Targeting Thalamic Nuclei
Lea Saab
11:45 AM - 12:45 PM EST Abstract 9-009 - Is there a difference in reduction of seizure frequency between transcutaneous and traditional VNS?
Jonadab Dos Santos Silva
11:45 AM - 12:45 PM EST Abstract 9-010 - Deep Brain Stimulation in Hemimegalencephaly with Medically Intractable Epilepsy: A Case Report
Delini Sivakumar, MD
11:45 AM - 12:45 PM EST Abstract 9-011 - A Single-Center Evaluation of Responsive Neurostimulation as Treatment for Drug-resistant Epilepsy
Sean Thomas Beattie, DO
11:45 AM - 12:45 PM EST Abstract 9-012 - An educational intervention to improve the efficacy of responsive neurostimulation scans: a single-center study
Roohi Katyal, MD
11:45 AM - 12:45 PM EST Abstract 15-001 - Impact of Gender and Race on Academic Achievements for Neurology Faculty.
Sima I. Patel, MD
11:45 AM - 12:45 PM EST Abstract 15-002 - A Student-Faculty Collaboration for Authentic Teaching of the Effects of Discrimination on Brain Health
Breanna Chachere
11:45 AM - 12:45 PM EST Abstract 15-003 - Creation of a Faculty Development Curriculum to Reduce the Impact of Racial/Ethnic Bias on Medical Students
Robert Ian Thompson-Stone, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 15-004 - Feasibility of an Interactive Zoom-based Antiracism Course for Academic Neurology Faculty
Neishay Ayub, MD
11:45 AM - 12:45 PM EST Abstract 15-005 - Academic Vascular Neurology - Lingering Effect of Gender Inequity on Compensation, Career and Burnout
Annie Ziyi He
11:45 AM - 12:45 PM EST Abstract 15-006 - Parental Leave Experience for Academic Neurology Faculty at 19 Academic Centers
Annie Ziyi He
11:45 AM - 12:45 PM EST Abstract 3-002 - Multiple Sclerosis Research Across the African Continent: A Systematic Review
Soonmyung Hwang
11:45 AM - 12:45 PM EST Abstract 3-003 - Most Opticospinal Demyelination is NMOSD, not MS- A 17-year UK Longitudinal Cohort Study
Mirasol Forcadela, MD
11:45 AM - 12:45 PM EST Abstract 3-004 - Effect of endocrine disrupting chemicals on early disease course in Multiple sclerosis
Tzu-ying Chuang, MD, PhD
11:45 AM - 12:45 PM EST Abstract 3-005 - Idiosyncrasy in a Spanish-speaking developing country and Employment: study of general population and Multiple Sclerosis
Sandra Vanotti
11:45 AM - 12:45 PM EST Abstract 3-006 - Characteristics of Multiple Sclerosis Patients by Phenotype: A Cross-Sectional Analysis Using the CLIMB Study
Gauruv Bose, MD
11:45 AM - 12:45 PM EST Abstract 3-007 - Oral health-related quality of life in multiple sclerosis and neuromyelitis optica spectrum disorder patients from Argentina
Veronica A. Tkachuk
11:45 AM - 12:45 PM EST Abstract 3-008 - Investigating the Prevalence of Psychiatric Disorders in Multiple Sclerosis with Autoimmune Comorbidities
Shin Chang
11:45 AM - 12:45 PM EST Abstract 3-009 - Symptom Severity in Early-stage Relapsing Remitting Multiple Sclerosis
Tamara Castillo-Trivino, MD, MAS, FAAN
11:45 AM - 12:45 PM EST Abstract 3-010 - Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis
Jon V. Riolo, PhD
11:45 AM - 12:45 PM EST Abstract 3-011 - Long-term Survival in Multiple Sclerosis is Improving
Stig Wergeland, MD, PhD
11:45 AM - 12:45 PM EST Abstract 3-012 - Use of individual measure and Z-scores to monitor disease course in Relapsing Multiple Sclerosis: A 1-year Prospective Study in a Single Center
Luis Rafael Solís-Tarazona, MD
11:45 AM - 12:45 PM EST Abstract 3-013 - Serum metabolic profile in early multiple sclerosis as predictor of long-term disease progression in BENEFIT
Marianna Cortese, MD, PhD
11:45 AM - 12:45 PM EST Abstract 3-014 - Cognitive Processing Speed Predicts Disability Milestones in Multiple Sclerosis
Danielle Marie Howard, MD
11:45 AM - 12:45 PM EST Abstract 3-015 - Baseline predictors of disability worsening among patients wth a Clinically Isolated Syndrome.
Enric Monreal Laguillo
11:45 AM - 12:45 PM EST Abstract 3-016 - Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression
Stephanie Victoria Meier
11:45 AM - 12:45 PM EST Abstract 3-017 - Predicting the Final Clinical Phenotype after the First Attack of Optic Neuritis
Shlok Sarin
11:45 AM - 12:45 PM EST Abstract 3-018 - Patterns and Predictors of Multiple Sclerosis Phenotype Transitions: A Longitudinal Analysis Using the CLIMB Study
Gauruv Bose, MD
11:45 AM - 12:45 PM EST Abstract 12-001 - Two Cases of Anti-PD1 Antibody Associated Neurological Immune-Related Adverse Effects
Grace Elizabeth Vitek, MD
11:45 AM - 12:45 PM EST Abstract 12-002 - From WEMINO To WEBINO With Unilateral LMN Facial Palsy
Rani Priyanka Vasireddy, MBBS
11:45 AM - 12:45 PM EST Abstract 12-003 - Neurological Manifestations in Post Renal Transplant Patients at Sindh Institute of Urology and Transplantation, Pakistan
Mughis Sheerani, MD
11:45 AM - 12:45 PM EST Abstract 12-004 - CT IR Cyst Lumbar Rupture Efficacy (CIRCLE): A case series
Katrina Bernardo, MD
11:45 AM - 12:45 PM EST Abstract 12-005 - Direct Clinical Applications of Natural Language Processing in Common Neurological Disorders: A Systematic Review
Ilana Lefkovitz, MD
11:45 AM - 12:45 PM EST Abstract 12-006 - Validation of a Neurofilament Light Chain Assay on a Clinical Autoanalyzer
Bradley Collier, PhD
11:45 AM - 12:45 PM EST Abstract 12-007 - The Frequency of Symptoms in Patients with a Diagnosis of Degenerative Cervical Myelopathy: Results of a Scoping Review
Lindsay Tetreault, MD, PhD
11:45 AM - 12:45 PM EST Abstract 6-001 - Refractory anti-NMDA Receptor Encephalitis During Pregnancy: Treatment and Neonatal Outcome with Review of Literature
Brandon J. Lew
11:45 AM - 12:45 PM EST Abstract 6-002 - Persistent meningitis followed by anti-NMDAR encephalitis: case series and literature review
Naoki Yamahara, MD
11:45 AM - 12:45 PM EST Abstract 6-003 - Whole-exome sequencing shows no specific mutation in ovarian teratoma of NMDAR-antibody encephalitis
Soo Hyun Ahn, MD
11:45 AM - 12:45 PM EST Abstract 6-004 - A Case series with comparative analysis of children and young adults with Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Rani Priyanka Vasireddy, MBBS
11:45 AM - 12:45 PM EST Abstract 6-005 - Characteristics and Treatment of anti-NMDAR Encephalitis in People Living with HIV: A Case Report and Literature Review
Emily I. White, MD
11:45 AM - 12:45 PM EST Abstract 6-006 - Longitudinal clinical outcomes, cognitive impairment, and mood symptoms in anti-NMDAR encephalitis
Annalisa Morgan, MD
11:45 AM - 12:45 PM EST Abstract 6-007 - Epidemiological and Demographic Characteristics Related to Social Determinants of Health in Patients with Anti-NMDAR Encephalitis
Sarah Shapiro
11:45 AM - 12:45 PM EST Abstract 6-008 - Anti-NMDAR encephalitis mimicking rapidly progressive neurodegenerative disorder in a toddler: a case report
Linda Nguyen, MD, PhD
11:45 AM - 12:45 PM EST Abstract 6-009 - Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis, Already at Diagnosis: The NEOS2 Model.
Juliette Brenner, MD
11:45 AM - 12:45 PM EST Abstract 6-010 - Post-Abortum NMDA Encephalitis
Rozaleen Aleyadeh, MD
11:45 AM - 12:45 PM EST Abstract 6-011 - Diagnostic Challenges in Pediatric Anti-NMDA Receptor Encephalitis
Melissa Ann Wright, MD
11:45 AM - 12:45 PM EST Abstract 6-012 - Missing Piece of Puzzle: Electro-Convulsive Therapy (ECT) in Patients with anti-NMDA Receptor Encephalitis
Lara Carine Wadi, MD
11:45 AM - 12:45 PM EST Abstract 6-013 - Biomarkers of Neuronal and Glial Injury in Leucine-Rich Glioma Inactivated-1 (LGI1) Autoimmune Encephalitis Patients: A Pilot Study
Tyler Lee Borko, BA, EMT-IV
11:45 AM - 12:45 PM EST Abstract 6-014 - A Pediatric Case of LGI1 Autoimmune Encephalitis Presenting with Faciobrachial Dystonic Seizures
Cheryl Fields, DO
11:45 AM - 12:45 PM EST Abstract 6-015 - Monitoring Faciobrachial Dystonic Seizures with Wearable Devices
Benjamin Henry Brinkmann, PhD
11:45 AM - 12:45 PM EST Abstract 6-016 - Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis
Saskia Raeuber, MD
11:45 AM - 12:45 PM EST Abstract 6-017 - Structural Lesion Facade Hiding an Insidious Autoimmune Encephalitis
Doris Xia, DO
11:45 AM - 12:45 PM EST Abstract 6-018 - New method to detect a diagnostic marker anti-NH2–terminal of a–enolase autoantibody for Hashimoto’s encephalopathy
Makoto Yoneda
11:45 AM - 12:45 PM EST Abstract 6-019 - Prognosticating Outcomes in Patients with CRMP5-IgG Associated Paraneoplastic Neurologic Disorders
Sanem Pinar Uysal, MD
11:45 AM - 12:45 PM EST Abstract 6-020 - Sudden Death in Autoimmune GFAP Astrocytopathy
Bishow Chandra Mahat, MD
11:45 AM - 12:45 PM EST Abstract 6-021 - Incidental Detection of Anti-IgLON5: A Diagnostic and Therapeutic Dilemma
Samir Alkabie, MD, MSc
11:45 AM - 12:45 PM EST Abstract 6-022 - Diaphragmatic paralysis associated with IgLON5 autoimmunity
Smathorn Thakolwiboon, MD
11:45 AM - 12:45 PM EST Abstract 6-023 - An Atypical Presentation of GABA-B Encephalitis
Mac DeHart-McCoyle, DO
11:45 AM - 12:45 PM EST Abstract 6-024 - Case Report of Anti-DPPX Encephalitis: Diagnostic Challenges in Hematologic-Oncologic Comorbidities
Emily Rose Fisher, MD
11:45 AM - 12:45 PM EST Abstract 6-025 - Anti-Tr/DNER Paraneoplastic Cerebellar Degeneration with Marked Cerebellar and Psychological Symptoms Responsive to Plasma Exchange
Paul Daniel Crane, MD
11:45 AM - 12:45 PM EST Abstract 6-026 - Paraneoplastic Neurologic Syndromes with ANNA-2/anti-Ri: a Contrasting Story of Two Cases
Nanthaya Tisavipat, MD
11:45 AM - 12:45 PM EST Abstract 6-027 - Clinical features and biomarkers of acute encephalitis with claustrum sign
Naoki Yamahara, MD
11:45 AM - 12:45 PM EST Abstract 6-028 - Anti-IgLON-5 Associated Neurological Disease Presenting with Bilateral Optic Neuritis, Orthostatic Intolerance, Sleep-Related Movements in Setting of Testicular Mass: Expanding Clinical Phenotypes in the Disease.
Aditi Vian Varma-Doyle, MD
11:45 AM - 12:45 PM EST Abstract 6-029 - Clinical Manifestation, Auxiliary Examination Features and Prognosis of GFAP Autoimmunity:a Chinese Cohort Study
Ka-Ho Wong
11:45 AM - 12:45 PM EST Abstract 6-030 - A Rare Case of Anti-SOX1 Antibody Positive Paraneoplastic Cerebellar Degeneration in Prostate Cancer
Hadi Mohammad Khanli, MD
11:45 AM - 12:45 PM EST Abstract 6-031 - Expanded Spectrum of Gad-65 Associated Autoimmune Encephalitis in Pediatric Patients.
Geetanjali Singh Rathore, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 6-032 - Pediatric CLIPPERS? Think Again!
Daniel Zhou, MD
11:45 AM - 12:45 PM EST Abstract 7-001 - Decline in Visual and Posterior Cortical Functions in Logopenic Progressive Aphasia
Neha Atulkumar Singh, PhD
11:45 AM - 12:45 PM EST Abstract 7-002 - Beyond impairment of language: empathy deficit in logopenic variant of Primary Progressive Aphasia
Giulia Giacomucci
11:45 AM - 12:45 PM EST Abstract 7-003 - Prevalence of Amyloid-Related Imaging Abnormalities in APOE4/4 Homozygotes with Early Alzheimer's Disease: Baseline Findings from Ongoing Clinical Trials of Oral Anti-Amyloid Agent ALZ-801 (Valiltramiprosate)
Sawsan (Susan) R. Abushakra, MD
11:45 AM - 12:45 PM EST Abstract 7-004 - A Novel Presenilin-1 Mutation Associated with Dementia and Spastic Paraplegia
Bridget Ollesch, MD
11:45 AM - 12:45 PM EST Abstract 7-005 - Clinical and Imaging Features of Early Onset Alzheimer’s Disease with a SORL1 Nonsense Variant
Conor T. Flavin, MD
11:45 AM - 12:45 PM EST Abstract 7-006 - Eligibility for Anti-Amyloid Treatment in a Population-Based Cohort Study of Aging
Rioghna R. Pittock
11:45 AM - 12:45 PM EST Abstract 7-007 - Early engagement with the Alzheimer’s disease (AD) community to gain insights into designing the SKYLINE trial in cognitively unimpaired people at risk for progression due to AD
Gesine Respondek, MD
11:45 AM - 12:45 PM EST Abstract 7-008 - A positive feedback loop between chronic lysosomal dysfunction and circRNAs in Alzheimer’s disease mouse models
Skarleth Cardenas Romero, Jr., MD
11:45 AM - 12:45 PM EST Abstract 7-009 - Identifying The Normal Function of Amyloid-Beta and Its Role in Alzheimer's Disease
Rachel Hunsucker
11:45 AM - 12:45 PM EST Abstract 7-010 - Associations Between CDR-Global and Meaningful Outcomes in Patients with Alzheimer’s Disease
Christian Wichmann
11:45 AM - 12:45 PM EST Abstract 7-011 - Medial Temporal Tau Predicts Memory Decline in Cognitively Unimpaired Elderly
Angela T.H. Kwan, MSc
11:45 AM - 12:45 PM EST Abstract 1-001 - Elucidating Mechanism of Ammonia Toxicity Using Cortical Organoids
Shawn Michael Barton, MD, PhD
11:45 AM - 12:45 PM EST Abstract 1-002 - Predictors Of Outcome In ICH Patients Initially Admitted To The ICU Who Are Transferred To Inpatient Rehab
Mohammad Jamil Ahmad, MD
11:45 AM - 12:45 PM EST Abstract 1-003 - Antidepressant Use and Associations with Delirium in Patients with Intracerebral Hemorrhage
Helen Yin Zhou
11:45 AM - 12:45 PM EST Abstract 1-004 - Acute Loss Of Brain Stem Reflexes Following Intracranial Hemorrhage
Stefano Malerba, MD
11:45 AM - 12:45 PM EST Abstract 1-005 - Clinical Trajectories in Patients with Severe Acute Brain Injury Requiring Mechanical Ventilation: A Descriptive Analysis of a Single-Center Prospective Observational Cohort Study
Natalie Smith
11:45 AM - 12:45 PM EST Abstract 1-006 - Long-Term Trajectories Following Severe Acute Brain Injury Requiring Mechanical Ventilation: A Mixed-methods Study to Assess Outcomes of Patients and Their Surrogate Decision-Makers
Sarah Wahlster, MD
11:45 AM - 12:45 PM EST Abstract 10-001 - Development and Validation of Machine Learning and Electronic Medical Records-Based Characterization of Stiff Person Syndrome
Soo Hwan Park
11:45 AM - 12:45 PM EST Abstract 10-003 - Autoimmune Isaac’s Syndrome With CASPR2 Antibodies Secondary To Mercury Toxicity
Sanita Raju, MD
11:45 AM - 12:45 PM EST Abstract 10-004 - Multisystem Proteinopathies (MSP) and MSP-like Disorders: Clinical-Pathological-Molecular Spectrum and Long-term Follow Up
Pitcha Chompoopong, MD
11:45 AM - 12:45 PM EST Abstract 10-005 - Clinical and Electrophysiological Presentation of a Patient with Multisystem Proteinopathy Associated with Valosin-Containing Protein Mutation
Matthew Halber, Other
11:45 AM - 12:45 PM EST Abstract 10-006 - Investigation of the Circulating Cell-free Mitochondrial DNA in Inflammation Related Neuromuscular Diseases
Can Ebru Kurt
11:45 AM - 12:45 PM EST Abstract 10-007 - A Rare Case of Kearns-Sayre Syndrome (KSS) with the Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Phenotype
Shaweta Khosa, MD
11:45 AM - 12:45 PM EST Abstract 10-008 - Progressive Longitudinally Extensive Myelopathy following Stroke in a Patient later found to have m.14484T>C Mutation in Leber’s Hereditary Optic Neuropathy (LHON) gene.
Kathryn Eszes, MD
11:45 AM - 12:45 PM EST Abstract 10-009 - Atypical Presentation of MELAS in a 7-year-old Male: A Case Report
Muhammad Khurram Afzal, MD
11:45 AM - 12:45 PM EST Abstract 10-010 - Twelve-month functional change in Limb Girdle Muscular Dystrophy R9 / 2I
Nicholas Elwood Johnson, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 10-011 - Muscle Ultrasound in an Open-Label Study of Losmapimod in Subjects with FSHD1
Joost Kools, MD
11:45 AM - 12:45 PM EST Abstract 10-012 - EMBARK, a Phase 3 Trial Evaluating Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Duchenne Muscular Dystrophy (DMD): Study Design and Baseline Characteristics
Francesco Muntoni, MD
11:45 AM - 12:45 PM EST Abstract 10-013 - Analysis of Vector Shedding Following Treatment with Delandistrogene Moxeparvovec (SRP-9001), an Investigational rAAVrh74-Based Gene Therapy for Duchenne Muscular Dystrophy (DMD)
Xiaolan Zhang, Other
11:45 AM - 12:45 PM EST Abstract 10-014 - Motor Performance and Lower Extremity Fat Fraction in Myotonic Dystrophies Type 1 and Type 2, and Controls
Diana Alejandra Madrid, MS
11:45 AM - 12:45 PM EST Abstract 10-015 - Caregivers Perspectives on Multidisciplinary Clinic Visits for Duchenne and Becker Muscular Dystrophy
Cade Michael Haynie
11:45 AM - 12:45 PM EST Abstract 4-001 - Social Work in Outpatient Neurology at a Safety-Net Hospital: A 200-Hour Profile
Cayla Vila, MD
11:45 AM - 12:45 PM EST Abstract 4-002 - US Census Tracts with Higher Proportions of Hispanics, Individuals with Disabilities, and Rural Location have Worse Geospatial Access to Neurological Care
Marisa P. McGinley, DO
11:45 AM - 12:45 PM EST Abstract 4-003 - Diversity, Equity, and Inclusion (DEI) Curriculum for Neurology Residency Program
Diana Andino, MD
11:45 AM - 12:45 PM EST Abstract 4-004 - Diversity, Equity, and Inclusion in Local Clinical Trials
Saketh Annam, MBBS
11:45 AM - 12:45 PM EST Abstract 4-005 - The Impact of Establishing a Diversity, Equity, and Inclusion Committee in a Single US Adult Neurology Residency Program
Mathura Ravishankar, MD
11:45 AM - 12:45 PM EST Abstract 4-006 - Broad Inclusion of Roles for a Neurology Department Diversity, Equity, and Inclusion Committee: Working Towards a Future of DEI Throughout Medicine
Olajide Abiola, MD
11:45 AM - 12:45 PM EST Abstract 4-007 - Increasing Ecopipam Exposure Improves Yale Global Tic Severity Scale-Total Tic Scores (YGTSS-TTS) in Children and Adolescents with Tourette Syndrome (TS): Results from a Population Pharmacokinetic (popPK) Model-Based Simulation Using D1AMOND Trial Data
Stephen Wanaski, PhD
11:45 AM - 12:45 PM EST Abstract 4-008 - Biofeedback-based Video Game Device to Treat Rage Attacks in Youth with Tourette Syndrome
Matthew Tae
11:45 AM - 12:45 PM EST Abstract 4-009 - High Dose Clonidine as a Novel Therapy for Symptomatic Status Dystonicus in a Pediatric Patient
Sean Bradley Woods
11:45 AM - 12:45 PM EST Abstract 4-010 - Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19
Maayan Joy Yakir, MD
11:45 AM - 12:45 PM EST Abstract 4-011 - Painful Hemidystonia - A Rare Presentation of Uremic Encephalopathy
Manasa Sudheendra, MBBS
11:45 AM - 12:45 PM EST Abstract 4-012 - Identifying Upper Extremity Features of Dystonia in People with Cerebral Palsy
Laura Gilbert, DO, MBA
11:45 AM - 12:45 PM EST Abstract 13-001 - The Experience of The COVID-19 Pandemic in a Population-Based Study of Cognitive Aging
Khaled Ghoniem, MD
11:45 AM - 12:45 PM EST Abstract 13-002 - COVID-19 Induced Elimination of First Taste Phenomenon
Drushti Deepak Birwatkar
11:45 AM - 12:45 PM EST Abstract 13-003 - Neurological manifestations in COVID-19 survivors: Observations in one of the largest only COVID-19 centers in México.
Monica Saray Rodriguez Rodríguez, Sr., MD
11:45 AM - 12:45 PM EST Abstract 13-004 - The Analysis of 607 Volunteers Shows a Reduction of Workability in Individuals With LONG-COVID Syndrome Associated With Neuropsychiatric Symptoms
Lucas Scárdua Silva, MD
11:45 AM - 12:45 PM EST Abstract 13-005 - Body mass index and its association with COVID-19 clinico-neurological outcomes: Findings from the Philippine CORONA study
Adrian Isidoro Espiritu, MD
11:45 AM - 12:45 PM EST Abstract 13-006 - Men with dementia are at increased risk of all-cause mortality following SARS-CoV-2 Vaccination
Jin Myoung Seok, MD
11:45 AM - 12:45 PM EST Abstract 5-001 - Antibiotic exposure and risk of Parkinson's disease in the United Kingdom: A case-control study
Gian D. Pal, MD
11:45 AM - 12:45 PM EST Abstract 5-002 - Neurophysiological Measures can be Used as Stratification Tool for Parkinson’s Disease Subtypes
Inbal Maidan
11:45 AM - 12:45 PM EST Abstract 5-003 - Categorizing Movement Disorders Associated with Toxic Exposures at Camp Lejeune Military Base
Jacqueline Hirschey, MD
11:45 AM - 12:45 PM EST Abstract 5-004 - Assessing the swallow tail sign in a real life scenario
Maria Agustina Ruiz Yanzi, MD
11:45 AM - 12:45 PM EST Abstract 5-005 - Partially reversible bilateral Lenticular fork sign and acute Parkinsonism in diabetic uremic syndrome
Yazan Nofal, MD
11:45 AM - 12:45 PM EST Abstract 5-006 - Amyloid plaque burden and dual tasking impairments on the Timed up and go test in Parkinson disease
Ashley Harrie
11:45 AM - 12:45 PM EST Abstract 5-007 - DaT Scan Positive Parkinson’s Disease in a Patient with Anti-MuSK Positive Myasthenia Gravis
Nada Ahmed, MD
11:45 AM - 12:45 PM EST Abstract 5-008 - Treatment Perceptions and Decision-Making Among Physicians Treating Essential Tremor
Margaret Gerbasi, PhD
11:45 AM - 12:45 PM EST Abstract 5-009 - Fragile-X-associated Tremor/Ataxia Syndrome in a Woman with Full Mutation: A Case Report
Serdar Kazanci, MD
11:45 AM - 12:45 PM EST Abstract 5-010 - Palato-ocular synchrony: Seeing what is behind closed eyelids in palatal tremor
Stephen G. Reich, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 5-011 - Cyst Formation following DBS Electrode Placement: A Rare Complication
Mustafa S. Siddiqui, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 5-012 - Does chromosome 16p12.1-p12.2 harbor a novel gene for essential tremor?
Muhammad Ismail Khalid Yousaf, MD
11:45 AM - 12:45 PM EST Abstract 5-013 - Utilization of intraoperative Subthalamic Nucleus local field potential recordings to guide postoperative Deep Brain Stimulation programming in Parkinson’s disease
Shumaila Anwer, MD
11:45 AM - 12:45 PM EST Abstract 5-014 - Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review
Rebekah L. S. Summers, PhD, PT
11:45 AM - 12:45 PM EST Abstract 5-015 - Patient perceptions and knowledge of Deep Brain Stimulation (DBS) in Parkinson’s disease (PD) (KNOW-DBS)
Austin Oblack, DO
11:45 AM - 12:45 PM EST Abstract 5-016 - Are Cognitively Impaired Patients Selectively Recruited to Pallidal Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)?
Sarah Marmol, MD
11:45 AM - 12:45 PM EST Abstract 5-017 - Real-World Outcomes in USA using DBS Systems with Directionality and Multiple Independent Current Control
Michael S. Okun, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 2-001 - Improving Early Recognition of Potentially Treatable Causes of Rapidly Progressive Dementia
Nihal Satyadev, MD, MPH
11:45 AM - 12:45 PM EST Abstract 2-002 - Clinical Experience with SATURN, a Public Domain Self-administered Cognitive Screening Test
David P. Bissig, MD
11:45 AM - 12:45 PM EST Abstract 2-003 - Cognitive Assessment is Feasible After Acute Stroke and Can Identify Co-occurrence of Spatial Neglect
Sabrina Hickle, PhD
11:45 AM - 12:45 PM EST Abstract 2-004 - The contribution of thalamic pathology to the clinical manifestations of frontotemporal dementia phenotypes
Eoin Finegan, MBBS
11:45 AM - 12:45 PM EST Abstract 2-006 - A comprehensive cognitive profile of patients with cervical dystonia
Shameer Rafee, MBBS
11:45 AM - 12:45 PM EST Abstract 2-007 - Towards a Trauma Subtype of Functional Neurological Disorder: Impact on Symptom Severity and Physical Health
David L. Perez, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 2-008 - The Effects of Anesthesia on Post-Operative Cognitive Dysfunction: A Systematic Review
Rayan Salah Ahmed Hassan, PhD
11:45 AM - 12:45 PM EST Abstract 2-009 - Analysis of Alzheimer’s Cerebrospinal Fluid Markers in Idiopathic Normal Pressure Hydrocephalus Pre- and Post-High Volume Lumbar Puncture
Lealani Mae Acosta, MD, FAAN
11:45 AM - 12:45 PM EST Abstract 2-010 - RT-QuIC Testing for Prions: Applying a Sensitive but Imperfect Test in Clinical Practice
Gregory S. Day, MD, MSc, FAAN
11:45 AM - 12:45 PM EST Abstract 11-001 - Effects of Low-Sodium Oxybate on 24-Hour Total Sleep Time: Data From a Phase 3 Clinical Study in Adults With Idiopathic Hypersomnia
Marisa Whalen
11:45 AM - 12:45 PM EST Abstract 11-002 - Increased Risk of Hypertension Onset Among Patients With Narcolepsy Newly Treated With High-Sodium Oxybate
Wayne Macfadden, MD,PT
11:45 AM - 12:45 PM EST Abstract 11-003 - Effectiveness and Optimization of Low-Sodium Oxybate in Participants With Narcolepsy Switching From High-Sodium Oxybate: Interim Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study
Shawn A. Candler, MD
11:45 AM - 12:45 PM EST Abstract 11-004 - Patient Preference and Nocturnal Experience With Oxybate Treatment for Narcolepsy: Interim Analysis of Data From RESTORE
John Harsh, PhD
11:45 AM - 12:45 PM EST Abstract 11-005 - Long-Term Safety of Once-Nightly Sodium Oxybate: Interim Analysis of Data From RESTORE
John Harsh, PhD
11:45 AM - 12:45 PM EST Abstract 11-006 - Long-term Safety During a Clinical Trial of Low-Sodium Oxybate in Participants With Narcolepsy With Cataplexy
Nancy R. Foldvary-Schaefer, DO, FAAN
Faculty Disclosures
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has stock in NeuroRx.
Paula R. Clemens, MD The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Jeffrey Alan Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Jeffrey Lee Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkahest. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Green Valley. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuaka. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for United Neuroscience. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cummings has received research support from NIH. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
L Dana DeWitt, MD Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Rodger J. Elble, MD, PhD, FAAN Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage . Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ES Therapeutics. Dr. Elble has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Applied Therapeutics. Dr. Elble has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis.
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Robert Freundlich, MD Dr. Freundlich has nothing to disclose.
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
John E. Greenlee, MD, FAAN Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Alan R. Hirsch, MD, FACP Dr. Hirsch has nothing to disclose.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Kerry H. Levin, MD, FAAN Dr. Levin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levin has received publishing royalties from a publication relating to health care. Dr. Levin has received publishing royalties from a publication relating to health care.
David W. Loring, PhD, FAAN Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Katherine D. Mathews, MD, FAAN Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Shrikant Mishra, MD, FAAN Dr. Mishra has nothing to disclose.
Ajay K. Misra, MD Dr. Misra has nothing to disclose.
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Solomon L. Moshe, MD, FAAN Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Moshe has received publishing royalties from a publication relating to health care. Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of study sections with NINDS.
M. Maral Mouradian, MD, FAAN Dr. Mouradian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Mouradian has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society for Experimental Neurotherapeutics. Dr. Mouradian has stock in Alnylam, Eli Lilly. The institution of Dr. Mouradian has received research support from NIH, Michael J. Fox Foundation for Parkinson's Research; American Parkinson Disease Association. Dr. Mouradian has received intellectual property interests from a discovery or technology relating to health care. Dr. Mouradian has a non-compensated relationship as a Board of Directors with ANA that is relevant to AAN interests or activities.
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Alexander D. Rae-Grant, MD, FAAN Dr. Rae-Grant has received publishing royalties from a publication relating to health care. Dr. Rae-Grant has received publishing royalties from a publication relating to health care.
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Lawrence M. Samkoff, MD, FAAN Dr. Samkoff has nothing to disclose.
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Michael J. Thorpy, MD Dr. Thorpy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Deborah Young Bradshaw, MD, FAAN The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
William O. Tatum, IV, DO, FAAN Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Blanca R. Vazquez, MD Dr. Vazquez has nothing to disclose.
Sawsan (Susan) R. Abushakra, MD Dr. Abushakra has received personal compensation for serving as an employee of Alzheon Inc. Dr. Abushakra has stock in Alzheon Inc. The institution of Dr. Abushakra has received research support from NIA. Dr. Abushakra has received intellectual property interests from a discovery or technology relating to health care.
Joseph O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
J. H. Harvey, DO Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals.
Anne C. Van Cott, MD, FAAN Dr. Van Cott has nothing to disclose.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Mark A. Agostini, MD Dr. Agostini has nothing to disclose.
Nancy R. Foldvary-Schaefer, DO, FAAN Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Page B. Pennell, MD, FAAN The institution of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Department of Defense. The institution of an immediate family member of Dr. Pennell has received research support from Environmental Protection Agency. The institution of an immediate family member of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Advanced Energy Consortium. Dr. Pennell has received publishing royalties from a publication relating to health care.
Bharathy E. Sundaram, MD Dr. Sundaram has nothing to disclose.
Ersin Tan, MD Dr. Tan has nothing to disclose.
Philip Scheltens, MD, PhD, FAAN Dr. Scheltens has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NOrdisk.
Elizabeth M. Berry-Kravis, MD, PhD The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Anavex. The institution of Dr. Berry-Kravis has received research support from Rett Syndrome Research Trust. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Orphazyme. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Erydel. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation.
Jonathan W. Mink, MD, PhD, FAAN The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Jennifer R L Friedman, MD An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Sinopia Biosciences. An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Pet Dx. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Friedman has stock in Friedman Bioventure .
A. M. Barrett, MD, FAAN The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD.
David J. Seiden, MD Dr. Seiden has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Dr. Seiden has received stock or an ownership interest from Avadel Pharmaceuticals.
Peter Hedera, MD Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Margherita Milone, MD, FAAN Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Peter Sillevis Smitt, MD The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care.
Matthew P. Wicklund, MD, FAAN Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Sookyong Koh, MD, PhD No disclosure on file
Mughis Sheerani, MD Dr. Sheerani has nothing to disclose.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Benedetta Nacmias Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Jeffrey L. Bennett, MD, PhD, FAAN Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Bio. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ImCyse. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Podoll. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Patterson. The institution of Dr. Bennett has received research support from Novartis. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
John D. Steffens, MD Dr. Steffens has nothing to disclose.
Kore K. Liow, MD, FACP The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Donald Gilbert, MD, FAAN Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex. The institution of Dr. Gilbert has received research support from PTC Therapeutics. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Conrad Weihl, MD, PhD Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casma therapeutics. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Weihl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser Moskowitz Edelman & Dicker LLP.
Jerome Honnorat, MD, PhD The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology.
Merce Boada Rovira, MD, PhD Dr. Boada Rovira has received personal compensation for serving as an employee of FUNDACIO ACE. ICNA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LILLY. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NORDISK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOIBERICA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SCHWABE PHARMA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NUTRICIA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERVIER. Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ZAMBON.
David Leppert, MD Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Urvi G. Desai, MD, FAAN Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Brian James Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Jason Viereck, MD, PhD Dr. Viereck has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Sean D. Ruland, MD Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.
Sevim Erdem-Ozdamar, MD No disclosure on file
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genethon. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lupin. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from UCB Pharma. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from NOVO Foundation. Prof. Vissing has received research support from Reneo Pharma. Prof. Vissing has received research support from Janssen Pharmaceuticals.
Jan A. Hillert, MD Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has nothing to disclose.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Kamala Marie Rodrigues, MD An immediate family member of Dr. Rodrigues has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spine Biopharma. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueJay Mobile-Health. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Spine Intervention Society. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State Farm. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kaiser Permanente. The institution of an immediate family member of Dr. Rodrigues has received research support from Relevant Medsystems.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Fernando J. Caceres, MD No disclosure on file
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Takahiro Iizuka, MD The institution of Dr. Iizuka has received research support from Astellas Pharma Inc.
Carmen Calles, MD Dr. Calles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Biogen, Roche, Teva, Novartis, Merck. Dr. Calles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Teva, Biogen, Roche, Novartis, Merck.
Richard H. Swartz, BSc MD PhD The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute.
Ana Belen Caminero Rodriguez, MD Dr. Caminero Rodriguez has nothing to disclose.
Ralph H. B. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Peter B. Kang, MD, FAAN Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapeutics. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NS Pharma. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teneofour. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Kang has received research support from Xtraordinary Joy Foundation. The institution of an immediate family member of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Centers for Disease Control and Prevention (CDC). The institution of Dr. Kang has received research support from National Institutes of Health (NIH). The institution of Dr. Kang has received research support from Food and Drug Administration. The institution of Dr. Kang has received research support from National Initiative for Cockayne Syndrome. The institution of Dr. Kang has received research support from Greg Marzolf Jr Foundation. An immediate family member of Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. Dr. Kang has received publishing royalties from a publication relating to health care. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Advisory Board with National Initiative for Cockayne Syndrome. Dr. Kang has a non-compensated relationship as a Medical Advisory Board with Speak Foundation that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a TRIAD Council with Hereditary Neuropathy Foundation that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a President with Child Neurology Society that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a Board Member with Child Neurology Foundation that is relevant to AAN interests or activities.
Paolo M. Moretti, MD The institution of Dr. Moretti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Inc. The institution of an immediate family member of Dr. Moretti has received research support from NIH. The institution of an immediate family member of Dr. Moretti has received research support from VHA. The institution of an immediate family member of Dr. Moretti has received research support from DOD.
Nathalie Jette, MD, MSc, FRCPC, FAAN Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Shilpa Chitnis, MD, PhD, FAAN, FANA Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott neuromodulation. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Skypass Foundation. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Skypass Foundation. Dr. Chitnis has received publishing royalties from a publication relating to health care.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Martin Tolar, MD, PhD Dr. Tolar has received personal compensation for serving as an employee of Alzheon. Dr. Tolar has received intellectual property interests from a discovery or technology relating to health care.
Sean J. Pittock, MD Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care.
Alexander M. Papanastassiou Alexander M. Papanastassiou has received intellectual property interests from a discovery or technology relating to health care.
Stephen B. Tatter, MD The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Ludy Chen Shih, MD, FAAN Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encora Therapeutics. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Shih has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WCG Medavante. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Shih has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley . The institution of Dr. Shih has received research support from Abbott. The institution of Dr. Shih has received research support from Praxis Precision Medicines. The institution of Dr. Shih has received research support from Tremor Research Group. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Consultant with German Accelerator. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Michael J. Fox Foundation. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Johns Hopkins.
Jack J. Lin, MD Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea.
Rana K. Zabad, MD, FAAN Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Pierre Tariot Pierre Tariot has received personal compensation for serving as an employee of Banner Alzheimer's Institute. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WebMD. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcadia. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioXcel. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNOVA. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Pierre Tariot has received intellectual property interests from a discovery or technology relating to health care.
Fadi B. Nahab, MD Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Bjorn E. Oskarsson, MD, FAAN Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AnnJi. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tsumura. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MediciNova. The institution of Dr. Oskarsson has received research support from Biogen. The institution of Dr. Oskarsson has received research support from Medicinova. The institution of Dr. Oskarsson has received research support from Cytokinetics. The institution of Dr. Oskarsson has received research support from Calico. The institution of Dr. Oskarsson has received research support from Mitsubishi. The institution of Dr. Oskarsson has received research support from Tsumura. The institution of Dr. Oskarsson has received research support from Sanofi. The institution of Dr. Oskarsson has received research support from AZTherapeutics. The institution of Dr. Oskarsson has received research support from Orion. The institution of Dr. Oskarsson has received research support from Esaii.
Deborah Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Neurocrine. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from SAGE. The institution of Dr. Hall has received research support from NIH.
Stephan Schuele, MD, FAAN Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.
Qutubuddin G. Khan, MBBS No disclosure on file
Tag-Eldin Sokrab, MD,PhD, FAAN Dr. Sokrab has nothing to disclose.
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Juichi Fujimori, MD No disclosure on file
Alberto Ascherio, MD, PhD The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Luis Brieva Ruiz, MD Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Sandra Vanotti Sandra Vanotti has nothing to disclose.
Christopher Anderson, MD Dr. Anderson has nothing to disclose.
Chad Carlson, MD, FAAN Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Jordan Scott Dubow, MD Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Gregory Owens, PhD No disclosure on file
Alessandro Serra, MD Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Fredrik L. Piehl, MD,PhD Dr. Piehl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel/Chugai. The institution of Dr. Piehl has received research support from UCB. The institution of Dr. Piehl has received research support from Merck KGaA. Dr. Piehl has received personal compensation in the range of $10,000-$49,999 for serving as a member scientific advisory board with Swedish Medical products Agency.
Kelly D. Foote, MD Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Rupert Sandbrink, MD, PhD Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Jason Lamar Aldred, MD, FAAN Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Atara. The institution of Dr. Aldred has received research support from Takeda. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Theravance. The institution of Dr. Aldred has received research support from Triplet Therapeutics. The institution of Dr. Aldred has received research support from UCB. The institution of Dr. Aldred has received research support from Cerevel . The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from Athira. The institution of Dr. Aldred has received research support from IRL. The institution of Dr. Aldred has received research support from NeuroDerm.
Natasha Frost, MD, FAAN Dr. Frost has nothing to disclose.
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. Dr. Siddiqui has received research support from Michael J. Fox Foundation. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Barrow Neurological Institute. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Beaumont Health. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Stanford. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with Cleveland Clinic.
Andrea S. Hakimi, DO Dr. Hakimi has nothing to disclose.
Jessica Zwerling, MD, FAAN Dr. Zwerling has nothing to disclose.
Asim Roy, MD Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai . Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Inspire. The institution of Dr. Roy has received research support from Jazz . The institution of Dr. Roy has received research support from Inspire. The institution of Dr. Roy has received research support from Avadel.
Gholam Adeli, MD Dr. Adeli has nothing to disclose.
Ryan Hays, MD, MBA, FAAN, FAES Dr. Hays has nothing to disclose.
Merja Soilu-Hanninen Merja Soilu-Hanninen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Merja Soilu-Hanninen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Merja Soilu-Hanninen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Merja Soilu-Hanninen has received research support from Biogen.
Atul Mahableshwarkar Atul Mahableshwarkar has received personal compensation for serving as an employee of Emalex Biosciences. Atul Mahableshwarkar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ecor1 Capital. Atul Mahableshwarkar has stock in Johnson & Johnson.
Sang Kun Lee, MD Prof. Lee has nothing to disclose.
Virginia J. Howard, PhD The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Vikas Kotagal, MD, FAAN Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Toni Pearson, MBBS Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Pearson has received research support from NIH.
Fabreena Napier, MD Dr. Napier has nothing to disclose.
Ihtsham Haq, MD, FAAN The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation. The institution of Dr. Haq has received research support from NIMH. Dr. Haq has a non-compensated relationship as a consultant with Medtronics that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Boston Scientific that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Abbott that is relevant to AAN interests or activities.
Claudio Gobbi, MD The institution of Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche.. Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche..
Kassandra L. Munger Ms. Munger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ms. Munger has received research support from Department of Defense.
Camilo A. Gutierrez, MD, FAAN Dr. Gutierrez has received research support from American academy of Neurology. Dr. Gutierrez has received personal compensation in the range of $0-$499 for serving as a Speaker with American Epilepsy Society.
Laura Marie Tormoehlen, MD, FAAN Dr. Tormoehlen has nothing to disclose.
Rohit Das, MD, FAAN Dr. Das has received personal compensation for serving as an employee of Concentra. Dr. Das has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for janicek. The institution of an immediate family member of Dr. Das has received research support from NIH.
Stephen Hantus, MD Dr. Hantus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hantus has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Alfred T. Frontera, Jr., MD Dr. Frontera has nothing to disclose.
Elizabeth Gerard, MD Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of an immediate family member of Dr. Gerard has received research support from Novo Nordisk. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University).
Oezguer Yaldizli, MD Dr. Yaldizli has nothing to disclose.
Timothy Cunniff, PharmD Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Cristina Granziera, MD, PhD Dr. Granziera has nothing to disclose.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Philips. The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Fresca. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. Dr. Bogan has a non-compensated relationship as a Chair with National Sleep Foundation that is relevant to AAN interests or activities.
Anna Marisa Cervantes-Arslanian, MD, FAAN Dr. Cervantes-Arslanian has nothing to disclose.
Anton P. Porsteinsson, MD Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MapLight Therapeutics. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Life Sciences. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognitive Research Corporation. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Athira. The institution of Dr. Porsteinsson has received research support from Avanir. The institution of Dr. Porsteinsson has received research support from Eisai. The institution of Dr. Porsteinsson has received research support from Eli Lilly. The institution of Dr. Porsteinsson has received research support from Athira. The institution of Dr. Porsteinsson has received research support from Genentech/Roche. The institution of Dr. Porsteinsson has received research support from Biohaven. The institution of Dr. Porsteinsson has received research support from Vaccinex. The institution of Dr. Porsteinsson has received research support from Alector. The institution of Dr. Porsteinsson has received research support from Cassava.
Luisa M. Villar Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Luisa M. Villar has received research support from European Union. The institution of Luisa M. Villar has received research support from Instituto de Salud Carlos III (Spanish Goverment).
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Kon Chu, MD, PhD Prof. Chu has nothing to disclose.
Maarten Jan Titulaer, MD, PhD The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from UpToDate Inc.
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Soon-Tae Lee, MD, PhD Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Autoimmune Encephalitis Alliance. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.
Daniel R. Gold, DO Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care.
Claire Creutzfeldt, MD The institution of Dr. Creutzfeldt has received research support from NINDS. The institution of Dr. Creutzfeldt has received research support from NINR.
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Daniel Ontaneda, MD, PhD, FAAN Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Val John Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Sergi Martinez-Ramirez, MD Dr. Martinez-Ramirez has nothing to disclose.
Jennifer Louise Whitwell, PhD Dr. Whitwell has nothing to disclose.
Deanna Saylor, MD, MHS The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Nicholas A. Frost, MD, PhD The institution of Dr. Frost has received research support from Simons Foundation. The institution of Dr. Frost has received research support from National Institutes of Health.
Melinda Magyari, MD Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Lilit Mnatsakanyan, MD Dr. Mnatsakanyan has nothing to disclose.
Utku Uysal, MD Dr. Uysal has nothing to disclose.
Teerin Liewluck, MD, FAAN Dr. Liewluck has nothing to disclose.
Michael Richard Zimbric, MD Dr. Zimbric has received personal compensation in the range of $0-$499 for serving as a Survey volunteer with Opinionsite.
Isabella D'Andrea Meira No disclosure on file
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
John Cirrito John Cirrito has nothing to disclose.
Robert Ian Thompson-Stone, MD, FAAN Dr. Thompson-Stone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Conway Homer PC.
Araya Puwanant, MD The institution of Dr. Puwanant has received research support from Muscular Dystrophy Association. The institution of Dr. Puwanant has received research support from NIH/NINDS. The institution of Dr. Puwanant has received research support from NIH/NINDS.
Shanna Patterson, MD Dr. Patterson has nothing to disclose.
Devon Conway, MD Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Doris G. Leung, MD The institution of Dr. Leung has received research support from US Department of Defense. The institution of Dr. Leung has received research support from Fulcrum Therapeutics. The institution of Dr. Leung has received research support from ML Bio Solutions, Inc.. The institution of Dr. Leung has received research support from Sarepta Therapeutics. The institution of Dr. Leung has received research support from Cumberland Pharmaceuticals. The institution of Dr. Leung has received research support from FibroGen Inc.. The institution of Dr. Leung has received research support from Astellas Pharma. The institution of Dr. Leung has received research support from University of Kansas Medical Center Research Institute. The institution of Dr. Leung has received research support from Pfizer, Inc.. The institution of Dr. Leung has received research support from Genethon. The institution of Dr. Leung has received research support from Harmony Biosciences. The institution of Dr. Leung has received research support from Edgewise Therapeutics.
Sol T. De Jesus, MD Dr. De Jesus has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic Inc.
Marisara Dieppa, MD Dr. Dieppa has nothing to disclose.
Anu Jacob, MD Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Jonathan Jagid Jonathan Jagid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic Inc. The institution of Jonathan Jagid has received research support from Boston Scientific. The institution of Jonathan Jagid has received research support from Medtronic Inc.
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Mariann Polgar-Turcsanyi Mariann Polgar-Turcsanyi has nothing to disclose.
James Rudolph The institution of James Rudolph has received research support from VA.
Louise R. Rodino-Klapac Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Doris Kung, DO, FAAN Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Afsaneh Shirani, MD Dr. Shirani has nothing to disclose.
Prashanthi Vemuri, PhD Dr. Vemuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Miller Medical Communications Inc.. The institution of Dr. Vemuri has received research support from NIH.
Lutz Achtnichts, MD No disclosure on file
Marcus D'Souza, MD Dr. D'Souza has nothing to disclose.
Rosario Blasco Quilez Rosario Blasco Quilez has nothing to disclose.
Jaime Masjuanvallejo Jaime Masjuanvallejo has nothing to disclose.
Jon V. Riolo, PhD Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Seema Nagpal, MD, FAAN Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mirati. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Midatech.
Lealani Mae Acosta, MD, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH.
Karima Benameur, MD Dr. Benameur has nothing to disclose.
Eva-Maria Wicklein, MD Dr. Wicklein has received personal compensation for serving as an employee of Bayer AG.
Brian Curran Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Marlieke De Bruijn No disclosure on file
Roshini Jain Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Gian D. Pal, MD Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Sima I. Patel, MD Dr. Patel has nothing to disclose.
John DeLuca, PhD, ABPP Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Valentina Bessi Valentina Bessi has nothing to disclose.
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Stefanie Mueller-Schunk Stefanie Mueller-Schunk has nothing to disclose.
Satoshi Minoshima Satoshi Minoshima has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Hamamatsu Photonics. The institution of Satoshi Minoshima has received research support from Nihon Medi-physics. The institution of Satoshi Minoshima has received research support from Fujifilm.
Virend Somers Virend Somers has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals . Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Respicardia. Virend Somers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer . Virend Somers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baker Tilly. The institution of Virend Somers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sleep Number . Virend Somers has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes Health . The institution of Virend Somers has received research support from National Institutes Health. The institution of Virend Somers has received research support from Sleep Number .
Rebecca L. Hurst, MD Dr. Hurst has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Paul Wilkinson law firm.
Dhanashri P. Miskin, MD Dr. Miskin has nothing to disclose.
Jelena M. Pavlovic, MD, PhD Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Siobhan Hutchinson, MD Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health.
Daniel Jose Correa, MD, MSc, FAAN Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Correa has stock in Aidin Inc. Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.
Cong Zhi Zhao, MD Dr. Zhao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Efficient CME. Dr. Zhao has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva.
Nicholas Elwood Johnson, MD, FAAN Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ML BIo . Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Entrada. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angle Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
David L. Perez, MD, FAAN Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. Dr. Perez has received publishing royalties from a publication relating to health care.
Jennifer Lyn Durphy, MD Dr. Durphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda.
Bob Bucelli, MD, PhD Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Bhooma Rajagopalan Aravamuthan, MD, PhD Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. An immediate family member of Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life Science, Inc.. Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Cynthia X. Wang, MD Dr. Wang has nothing to disclose.
Jerome Barakos Jerome Barakos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Jerome Barakos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Jeremiah Aakre Jeremiah Aakre has nothing to disclose.
Amanda Lee Piquet, MD, FAAN The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Firas Fahoum Firas Fahoum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Firas Fahoum has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai.
Michael Khalil Michael Khalil has nothing to disclose.
Christopher Schwarz Christopher Schwarz has received personal compensation for serving as an employee of Mayo Clinic. The institution of Christopher Schwarz has received research support from NIH.
Christopher Streib, MD Dr. Streib has nothing to disclose.
Joyce Suhy, PhD Dr. Suhy has nothing to disclose.
Stig Wergeland, MD, PhD Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Wergeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wergeland has received research support from Biogen.
Peter Bede, MD, PhD Dr. Bede has nothing to disclose.
Ernst-Wilhelm Radue, MD Dr. Radue has nothing to disclose.
Gerd Meyer Zu Horste, MD Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB. The institution of Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Meyer Zu Horste has received research support from Merck KGaA. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Sasha Alick-Lindstrom, MD, FAAN, FACNS,FAES Dr. Alick-Lindstrom has nothing to disclose.
Ritesh Ramdhani, MD Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accorda. Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance.
Christoph Wandel, MD, PhD Christoph Wandel, MD, PhD has received personal compensation for serving as an employee of F Hoffmann-LaRoche AG. Christoph Wandel, MD, PhD has stock in F Hoffmann-La Roceh AG, Basel, CH; Bayer AG, Leverkusen, FRG.
Roland Dominic Jamora Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Tamara Castillo-Trivino, MD, MAS, FAAN Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Jafar Kafaie, MD, PhD Dr. Kafaie has nothing to disclose.
Scott K. Adney, MD Dr. Adney has received research support from NINDS.
Ghazala Perven, MD Dr. Perven has nothing to disclose.
Jane B. Allendorfer, PhD An immediate family member of Dr. Allendorfer has received personal compensation for serving as an employee of Northport Health Services, LLC. The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Nico Melzer Nico Melzer has nothing to disclose.
Eugenio Mercuri Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis, Scholar Rock, Cytokinetics. Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis. The institution of Eugenio Mercuri has received research support from biogen.
Vineet Punia, MD Dr. Punia has nothing to disclose.
Pedro Rosa Neto, MD, PhD The institution of Dr. Rosa Neto has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk.
Sarah Wahlster, MD Dr. Wahlster has nothing to disclose.
Steven Richard Dunham, Jr., MD Dr. Dunham has nothing to disclose.
Eduardo Aguera Morales, MD, PhD Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Imran H. Quraishi, MD, PhD The institution of Dr. Quraishi has received research support from NeuroPace. The institution of Dr. Quraishi has received research support from Biogen. The institution of Dr. Quraishi has received research support from Praxis Precision Medicines.
Susan Erin Duberstein Coad, MD Dr. Duberstein Coad has nothing to disclose.
Zhi-Jian Chen, MD Dr. Chen has nothing to disclose.
Nicolas N. Madigan, MD Dr. Madigan has nothing to disclose.
Hesham Ahmed Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Michael L. Morgan, MD, PhD Dr. Morgan has nothing to disclose.
Jenny Linnoila, MD, PhD Dr. Linnoila has received research support from NIH/NINDS. Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/vaccine injury compensation program.
Linda Pax Lowes, PT PhD The institution of Ms. Lowes has received research support from Sarepta Therapeutics.
Christa O'hana San Luis Nobleza, MD Dr. Nobleza has nothing to disclose.
Drew S. Kern, MD, FAAN Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Claude Steriade, MD The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals.
Samir Alkabie, MD, MSc Dr. Alkabie has nothing to disclose.
Matthew Brier, MD Dr. Brier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Brier has received research support from NIH.
Jennifer Anne Vermilion, MD The institution of Dr. Vermilion has received research support from Tourette Association of America, American Academy of Neurology and American Brain Foundation. The institution of Dr. Vermilion has received research support from Centers for Disease Control.
Giulio Disanto, MD, PhD The institution of Dr. Disanto has received research support from Swiss MS Sociery.
Aline Herlopian, MD Dr. Herlopian has nothing to disclose.
Chahin Pachai Chahin Pachai has received personal compensation for serving as an employee of Bristol Myers Squibb. Chahin Pachai has stock in Bristol-Myers Squibb.
Thomas Thesen, PhD Prof. Thesen has nothing to disclose.
Charles Esenwa, MD Dr. Esenwa has nothing to disclose.
Roman Skowronski, "MD, PhD" Dr. Skowronski has nothing to disclose.
Tzu-ying Chuang, MD, PhD Dr. Chuang has nothing to disclose.
Rodrigo Zepeda Garcia, MD The institution of Dr. Zepeda Garcia has received research support from NIH.
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Saif Huda, MD Dr. Huda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint.
Andrea Lendaris, MS, MD Dr. Lendaris has nothing to disclose.
Lei Liu, MD, PhD Dr. Liu has nothing to disclose.
Lindsay N. Alfano, PT Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care.
Nobuaki Yoshikura, MD, PhD Dr. Yoshikura has nothing to disclose.
Panagiotis Kassavetis, MD Dr. Kassavetis has nothing to disclose.
Sarah E. Nelson, MD, MPH Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Spark Healthcare. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Healthcare. Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journal. Dr. Nelson has received publishing royalties from a publication relating to health care.
Brin Freund, MD Dr. Freund has nothing to disclose.
Lisa E. Farnett Ms. Farnett has received personal compensation for serving as an employee of Sanofi. Ms. Farnett has stock in Sanofi.
Jose Luis Sanchez Menoyo, MD Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Farwa Ali, MD Dr. Ali has nothing to disclose.
Philip W. Tipton, MD Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Benjamin R. Kummer, MD Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum Partners. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for AlphaSights. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for Gehrson Lehrman Group . Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syapse. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuraHealth. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syntrillo. Dr. Kummer has stock in Syntrillo. The institution of Dr. Kummer has received research support from Icahn School of Medicine at Mount Sinai.
June Yoshii-Contreras, MD Dr. Yoshii-Contreras has nothing to disclose.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Dubey has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Moffit Cancer Center . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Geetanjali Singh Rathore, MD, FAAN Dr. Rathore has nothing to disclose.
Sneha Mantri, MD Dr. Mantri has received personal compensation in the range of $0-$499 for serving as a Consultant for Deep Brain Innovations, LLC. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grey Matter Technology. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
Nagma Dalvi, MD Dr. Dalvi has nothing to disclose.
Ajitesh Ojha, MD Dr. Ojha has nothing to disclose.
Michael E. Reznik, MD Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Halley Alexander, MD Dr. Alexander has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Alexander has received research support from National Center for Advancing Translational Sciences, National Institute of Health, Grant KL2TR001421.
Bart Chwalisz, MD Dr. Chwalisz has nothing to disclose.
Jared Bartell, MD Dr. Bartell has nothing to disclose.
Mohamed Darwish, MD Dr. Darwish has nothing to disclose.
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Myriam Abdennadher, MD The institution of Dr. Abdennadher has received research support from Grinspoon Foundation.
Eddie Jones, BA Eddie Jones, BA has nothing to disclose.
Kerry Mutch Kerry Mutch has nothing to disclose.
Sophie Arnould Sophie Arnould has nothing to disclose.
Benjamin Henry Brinkmann, PhD Dr. Brinkmann has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka Pharmaceuticals. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Brinkmann has a non-compensated relationship as a Co-Investigator with Medtronic Inc. that is relevant to AAN interests or activities.
Keiko Aun Fukuda, MD Dr. Fukuda has nothing to disclose.
Anna Glaser Anna Glaser has nothing to disclose.
Sanjeet S. Grewal, MD Sanjeet S. Grewal, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Hirofumi Komaki Hirofumi Komaki has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nippon Shinyaku. Hirofumi Komaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Hirofumi Komaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics Inc. Hirofumi Komaki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai .
Aravindhan Veerapandiyan, MD Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AMO Pharma, AveXis, Biogen, Edgewise Therapeutics, FibroGen, Novartis, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Scholar Rock, Catalyst, Lupin. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Frances Weaver Frances Weaver has received personal compensation for serving as an employee of PCORI.
Anthony M. Bradshaw, MD Dr. Bradshaw has nothing to disclose.
Alexander G. Doyle, MD Dr. Doyle has nothing to disclose.
K. H. Vincent Lau, MD Dr. Lau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Lau has received research support from Amyloidosis Foundation.
Rebecca Pollard, MD Dr. Pollard has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Clinical and Translational Neurology.
Madison Pilato, MD Dr. Pilato has nothing to disclose.
Akiko Matsunaga, MD AKIKO MATSUNAGA, MD has nothing to disclose.
Sari Atula, MD, PhD Sari Atula, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sari Atula, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sari Atula, MD, PhD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Sari Atula, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Sari Atula, MD, PhD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Jed Black, MD Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in .
Cynthia Emilie Armand, MD Dr. Armand has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spire Learning. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Zain Guduru, MD, FAAN Dr. Guduru has nothing to disclose.
Marisa P. McGinley, DO Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Novartis. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH.
Meagen Salinas, MD The institution of Dr. Salinas has received research support from North Texas VA Health Care System New Investigator Award.
Jennifer Marie Martinez-Thompson, MD Dr. Martinez-Thompson has nothing to disclose.
Neishay Ayub, MD The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Jonathan D. Zurawski, MD The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation.
Cody Louis Nathan, MD Dr. Nathan has nothing to disclose.
Chen Zhao, MD Dr. Zhao has nothing to disclose.
Simona Treidler, MD Dr. Treidler has nothing to disclose.
Melissa Ann Wright, MD Dr. Wright has nothing to disclose.
Gauruv Bose, MD Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. The institution of Dr. Bose has received research support from Multiple Sclerosis Society of Canada.
Adrian Laxton Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris .
Anat Mirelman Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Bruno Benitez Bruno Benitez has nothing to disclose.
Gilles Edan Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Laura Navarro Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen idec. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme.
Leorah Aude Emmanuelle Freeman, MD, PhD Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for WebMD. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MSAA. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Participant in educational interview with Multiple Sclerosis Association of America.
Makoto Yoneda The institution of Makoto Yoneda has received research support from Cosmic Corporation.
Mateus Nogueira Mateus Nogueira has nothing to disclose.
Nicholas Thompson Nicholas Thompson has nothing to disclose.
Sandra Kletzel Sandra Kletzel has received personal compensation for serving as an employee of Edward Hines Jr VA Hospital. Sandra Kletzel has received research support from VAH.
Sean Selva Sean Selva has nothing to disclose.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Leah Blank, MD The institution of an immediate family member of Dr. Blank has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Myers Squibb (Legal). The institution of Dr. Blank has received research support from American Epilepsy Foundation/Epilepsy Foundation/NORSE Foundation. The institution of Dr. Blank has received research support from NIA (Mount Sinai OAIC).
Jessica Langbaum, PhD Dr. Langbaum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Denovo Biopharma. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Langbaum has received research support from Eli Lilly.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Maria Vassilaki, MD, PhD The institution of Dr. Vassilaki has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd . Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
Vijay K. Ramanan, MD, PhD The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Emily Rose Fisher, MD Dr. Fisher has nothing to disclose.
Laura Gilbert, DO, MBA Dr. Gilbert has nothing to disclose.
Keisuke Ueda, MD Dr. Ueda has nothing to disclose.
David P. Bissig, MD Dr. Bissig has received personal compensation in the range of $100,000-$499,999 for serving as a Physician with University of California - Davis.
Pria Anand, MD Dr. Anand has nothing to disclose.
Sarah R. Durica, MD An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Stephanie L. Bissonnette, DO The institution of Dr. Bissonnette has received research support from Michael J Fox Foundation. The institution of Dr. Bissonnette has received research support from Cogan Family Foundation.
Ilena George, MD The institution of Dr. George has received research support from Biogen.
Carla D. Zingariello, DO The institution of Dr. Zingariello has received research support from ML Bio. The institution of Dr. Zingariello has received research support from Edgewise Therapeutics.
Lakshman Narain Arcot Jayagopal, MD Dr. Arcot Jayagopal has nothing to disclose.
DonRaphael Pratt Wynn, MD Dr. Wynn has nothing to disclose.
Vishakhadatta Mathur Kumaraswamy, MD The institution of Dr. Mathur Kumaraswamy has received research support from Woolsey Pharmaceuticals.
Suma Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from National MS Society.
Christian Cameron Prusinski, DO Dr. Prusinski has nothing to disclose.
Amy Kunchok, MBBS Dr. Kunchok has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon therapeutics . Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Adrian Budhram, MD Dr. Budhram has nothing to disclose.
Jumana Tariq A Alshaikh, MD Dr. Alshaikh has nothing to disclose.
Venka Veerappan, MD Dr. Veerappan has nothing to disclose.
Elina Zakin, MD The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Katherine A. Zarroli, MD Dr. Zarroli has nothing to disclose.
Taylor Jane Saraceno Ms. Saraceno has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cumming Foundation. The institution of Ms. Saraceno has received research support from I-Mab Biopharma.
Susana Sainz de la Maza Susana Sainz de la Maza has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Merck, Novartis, Roche and Sanofi-Genzyme.
Mercedes Espiño No disclosure on file
Hadi Mohammad Khanli, MD Dr. Mohammad Khanli has nothing to disclose.
Shufang Wang Shufang Wang has received personal compensation for serving as an employee of Sarepta Therapeutics INC. Shufang Wang has received stock or an ownership interest from Sarepta Therapeutics INC.
Mat D. Davis Mat D. Davis has received personal compensation for serving as an employee of Teva pharmaceuticals. Mat D. Davis has received stock or an ownership interest from Teva Pharmaceuticals.
Racquel *use 295099 Whyte No disclosure on file
Ramya Sampath Mrs. Sampath has nothing to disclose.
Ina Schroder No disclosure on file
Veronica A. Tkachuk Veronica A. Tkachuk has nothing to disclose.
Inbal Maidan Dr. Maidan has nothing to disclose.
Erik Middlebrooks Erik Middlebrooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Varian Medical Systems Inc. Erik Middlebrooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Corp. The institution of Erik Middlebrooks has received research support from Varian Medical Systems Inc.
Chiara Claudia Zecca, MD The institution of Dr. Zecca has received research support from Ente Ospedaliero Cantonale.
Alexandria Sadasivan, MD Dr. Sadasivan has nothing to disclose.
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS.
Elise Poole Ms. Poole has nothing to disclose.
Maria Campo Amigo Maria Campo Amigo has nothing to disclose.
Virginia DeLasHeras Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation .
Tobias Derfuss An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has received stock or an ownership interest from Novartis. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen.
Shahd Hassan Mahmoud Hamid, MBBS Dr. Hamid has nothing to disclose.
Parneet Kaur Grewal, MD Dr. Grewal has nothing to disclose.
Linda Nguyen, MD, PhD Dr. Nguyen has nothing to disclose.
Eoin Finegan, MBBS Dr. Finegan has nothing to disclose.
Kalea Lynn Colletta, DO Dr. Colletta has nothing to disclose.
Katrina Bernardo, MD Dr. Bernardo has nothing to disclose.
Simon Thebault, MD Dr. Thebault has nothing to disclose.
Amanda Lynn Porter, MD Dr. Porter has nothing to disclose.
Mhd. Omar Subei, MD Dr. Subei has nothing to disclose.
Smathorn Thakolwiboon, MD Dr. Thakolwiboon has nothing to disclose.
Jonathan Gursky, MD Dr. Gursky has nothing to disclose.
D. James Ballard D. James Ballard has nothing to disclose.
Pitcha Chompoopong, MD Dr. Chompoopong has nothing to disclose.
Marianna Cortese, MD, PhD Dr. Cortese has received personal compensation in the range of $500-$4,999 for serving as a speaker at educational event with Roche.
Vibhor Krishna Vibhor Krishna has nothing to disclose.
Anke Salmen The institution of Anke Salmen has received research support from Baasch Medicus Foundation. The institution of Anke Salmen has received research support from Swiss MS Society. The institution of Anke Salmen has received research support from Medical Faculty of the University of Bern. Anke Salmen has received personal compensation in the range of $500-$4,999 for serving as a speaker with Bristol Myers Squibb, CSL Behring, Novartis, Roche.
Marco Schreurs Marco Schreurs has nothing to disclose.
Colin Shapiro Colin Shapiro has nothing to disclose.
Stefan Sillau The institution of Stefan Sillau has received research support from Alzheimer's Association. The institution of Stefan Sillau has received research support from Hewitt Family Foundation; State of Colorado. The institution of Stefan Sillau has received research support from PCORI. The institution of Stefan Sillau has received research support from NINR. The institution of Stefan Sillau has received research support from Michael J. Fox Foundation. The institution of Stefan Sillau has received research support from Department of Defense. The institution of Stefan Sillau has received research support from Colorado Department of Public Health and Environment. The institution of Stefan Sillau has received research support from Benign Essential Blepharospasm Research Foundation. Stefan Sillau has a non-compensated relationship as a Statistician with Novartis that is relevant to AAN interests or activities. Stefan Sillau has a non-compensated relationship as a Statistician with Biogen that is relevant to AAN interests or activities.
Stephen Wanaski, PhD Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
Serdar Kazanci, MD Dr. Kazanci has nothing to disclose.
Shawn A. Candler, MD Dr. Candler has received research support from Jazz Pharmaceuticals .
Umar Yazdani Mr. Yazdani has nothing to disclose.
Mathura Ravishankar, MD Dr. Ravishankar has nothing to disclose.
Meghan Zorn, PA Ms. Zorn has nothing to disclose.
Emily I. White, MD Dr. White has nothing to disclose.
Can Ebru Kurt Can Ebru Kurt has nothing to disclose.
Akio Kimura, MD Dr. Kimura has nothing to disclose.
Henrique Jannuzzelli Prado, MD No disclosure on file
Vanessa Salasky, MD Dr. Salasky has nothing to disclose.
Emma Wallace, MD, PhD Dr. Wallace has nothing to disclose.
Christopher Ryan Barton, MD Dr. Barton has nothing to disclose.
Tammy L. Smith, MD, PhD The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has a non-compensated relationship as a participant with Euroimmun Academy, receiving travel support to attend, that is relevant to AAN interests or activities.
Danielle Marie Howard, MD The institution of Dr. Howard has received research support from Genentech. The institution of Dr. Howard has received research support from Novartis. Dr. Howard has received personal compensation in the range of $50,000-$99,999 for serving as a Clinical Fellow with National Multiple Sclerosis Society.
Kasra Sarhadi, MD Dr. Sarhadi has nothing to disclose.
Melanie Braun, MD Dr. Braun has nothing to disclose.
Aristide Merola, MD, PhD Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Raffaella Umeton, MD Dr. Umeton has nothing to disclose.
Vishal Mandge, MD Dr. Mandge has nothing to disclose.
Nicole Brescia, MD Dr. Brescia has nothing to disclose.
Ahmad Sawalha, MD Dr. Sawalha has nothing to disclose.
Sepehr Sani Sepehr Sani has nothing to disclose.
Christine Strippel Christine Strippel has nothing to disclose.
Adrian Isidoro Espiritu, MD Dr. Espiritu has nothing to disclose.
Julio Dotor Garcia-Soto JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Lucía *use 253857 Forero Lucía Forero has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Lucía Forero has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche .
Nicole Mazwi Nicole Mazwi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Morrison Mahoney.
Suzanne Liu, MD The institution of an immediate family member of Dr. Liu has received research support from NIH.
Christian Barro, MD, PhD Dr. Barro has nothing to disclose.
Shaweta Khosa, MD Dr. Khosa has nothing to disclose.
Muhammad Ismail Khalid Yousaf, MD Dr. Yousaf has nothing to disclose.
Giulia Giacomucci Ms. Giacomucci has nothing to disclose.
Maxine Dibue-Adjei, PhD Maxine Dibue-Adjei has received personal compensation for serving as an employee of LivaNova PLC. Maxine Dibue-Adjei has stock in LivaNova PLC.
Javier Sotoca Fernandez No disclosure on file
Nupur Greene Nupur Greene has nothing to disclose.
Rani Priyanka Vasireddy, MBBS Dr. Vasireddy has nothing to disclose.
Rebekah L. S. Summers, PhD, PT Rebekah Summers has received personal compensation for serving as an employee of Medtronic. Rebekah Summers has received research support from National Institute of Health.
Ruth Monaghan No disclosure on file
Samantha Paige Myers Ms. Myers has nothing to disclose.
Diana Andino, MD Dr. Andino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Multiple Sclerosis American Association. Dr. Andino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Andino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Roohi Katyal, MD Dr. Katyal has nothing to disclose.
Sarah Marmol, MD Dr. Marmol has nothing to disclose.
Anam Syed, DO Dr. Syed has nothing to disclose.
Shazia Mirza, MBBS Dr. Mirza has nothing to disclose.
Muhammad Bilal Tariq, MBBS Dr. Tariq has nothing to disclose.
Monica Buckley, MD,PhD Dr. Buckley has nothing to disclose.
Shrishti Saxena Shrishti Saxena has nothing to disclose.
Nassim Matin, MD Dr. Matin has nothing to disclose.
Sifat Sharmin, PhD Dr. Sharmin has nothing to disclose.
Maria Florendo, MD Dr. Florendo has nothing to disclose.
Ryan Kammeyer, MD The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Brandon J. Lew The institution of Mr. Lew has received research support from NIH.
Mary Clare McKenna, MB BCh, BAO Dr. McKenna has nothing to disclose.
Hrishikesh A. Lokhande Mr. Lokhande has nothing to disclose.
Rozaleen Aleyadeh, MD Dr. Aleyadeh has nothing to disclose.
Amaia Munoz Amaia Munoz has nothing to disclose.
Arunima Kapoor Arunima Kapoor has nothing to disclose.
Lilly Chen Lilly Chen has received personal compensation for serving as an employee of Boston Scientific .
Shilpa Krishnan The institution of Shilpa Krishnan has received research support from National Instuitutes of Health. Shilpa Krishnan has received personal compensation in the range of $10,000-$49,999 for serving as a Research Consultant with The Board of Medicine.
Carl Froilan Leochico No disclosure on file
Bryce Chang, MD Mr. Chang has nothing to disclose.
Cristina Polito Cristina Polito has nothing to disclose.
Mar Guasp, MD Dr. Guasp has nothing to disclose.
Kimihiko Kaneko Kimihiko Kaneko has nothing to disclose.
Firas Dabbous Firas Dabbous has stock in Abbvie, Abott Labs, Pfizer and Thermo Fisher Scientific.
Steven Ojemann Steven Ojemann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Steven Ojemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager Therapeutics. The institution of Steven Ojemann has received research support from Voyager Therapeutics.
Aditi Vian Varma-Doyle, MD Dr. Varma-Doyle has nothing to disclose.
Spyridoula Tsetsou, MD Dr. Tsetsou has nothing to disclose.
Karlien Mul The institution of Karlien Mul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences.
Lori Daiello Lori Daiello has nothing to disclose.
Richard Jones Richard Jones has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American Geriatrics Society.
Carol Reid Carol Reid has received personal compensation for serving as an employee of Roche Products Ltd. Carol Reid has stock in Roche Products Ltd.
Eileen Leary, PhD Dr. Leary has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Leary has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proper. Dr. Leary has stock in Jazz Pharmaceuticals.
Bradley Lega, MD The institution of Bradley Lega has received research support from NIH.
Kjetil Bjornevik, MD, PhD The institution of Dr. Bjornevik has received research support from Michael J. Fox Foundation. The institution of Dr. Bjornevik has received research support from National Multiple Sclerosis Society. The institution of Dr. Bjornevik has received research support from Department of Defense.
Clary B. Clish The institution of Clary B. Clish has received research support from NIH. Clary B. Clish has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Lisa Kay Peterson, PhD The institution of Dr. Peterson has received research support from Kronus.
and Named Authors of The MSBase Study Group No disclosure on file
Joshua M. Rosenow, MD, FAANS, FACS Joshua M Rosenow, MD, FAANS, FACS has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation.
Keisuke Imai Keisuke Imai has nothing to disclose.
Lars Forsberg Lars Forsberg has nothing to disclose.
Jacqueline Hirschey, MD Dr. Hirschey has nothing to disclose.
Mariam Hull, MD Dr. Hull has received publishing royalties from a publication relating to health care.
Jin Myoung Seok, MD Jin Myoung Seok has nothing to disclose.
Italo Karmann Aventurato, MD Dr. Karmann Aventurato has received research support from Coordenadoria de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES). Dr. Karmann Aventurato has received research support from Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP).
Valentina Berti Valentina Berti has nothing to disclose.
Alexandria Wise-Brown, PhD Dr. Wise-Brown has received personal compensation for serving as an employee of Genentech.
Michele Matarazzo, MD Dr. Matarazzo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society.
Gesine Respondek, MD Gesine Respondek, MD has received personal compensation for serving as an employee of Hoffmann-La Roche. Gesine Respondek, MD has stock in Hoffmann-La Roche.
Teresa Steininger Teresa Steininger has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Teresa Steininger has stock in Jazz Pharmaceuticals.
Annalisa Morgan, MD Dr. Morgan has nothing to disclose.
Rachel Galioto Rachel Galioto has nothing to disclose.
Izanne Roos Izanne Roos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Izanne Roos has received research support from MSIF-ARSEP. Izanne Roos has received research support from Melbourne Research Scholarship. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Merck. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Roche.
Jorge Maurino Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Jose A Pineda-Pardo Jose A Pineda-Pardo has nothing to disclose.
Michelle Anlacan Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as a Consultant for Torrent Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medichem Philippines. Michelle Anlacan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi Eisai Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natrapharm Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's disease association of the philippines. Michelle Anlacan has received research support from Philippine Council for Health Research and Development. Michelle Anlacan has received research support from Philippine Neurological Association.
John Winslow, PhD Dr. Winslow has received personal compensation for serving as an employee of Monogram Biosciences/Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
Christos John Petropoulos, PhD Dr. Petropoulos has received personal compensation for serving as an employee of Monogram Biosciences-Labcorp. Dr. Petropoulos has received stock or an ownership interest from Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
Edgar Carnero Contentti Edgar Carnero Contentti has nothing to disclose.
Salvatore Mazzeo Mr. Mazzeo has nothing to disclose.
Shameer Rafee, MBBS Dr. Rafee has nothing to disclose.
Diego Silva Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Raul Anwar Garcia Santos, MD Dr. Santos has nothing to disclose.
Yarema B Bezchlibnyk Yarema B Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PMT Corporation. Yarema B Bezchlibnyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Yarema B Bezchlibnyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Yarema B Bezchlibnyk has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic.
Zakir Iqbalbhai Shaikh, MBBS Dr. Shaikh has nothing to disclose.
Anna Zolyan, MD Dr. Zolyan has nothing to disclose.
Christine Cliatt Brown, MD Dr. Cliatt Brown has nothing to disclose.
Anastasia Vishnevetsky, MD The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Nikhil Modak, MD Dr. Modak has nothing to disclose.
Daniel Zhou, MD Dr. Zhou has nothing to disclose.
Bridget Ollesch, MD Dr. Ollesch has nothing to disclose.
Nadia Khalil, MD Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a Resident and Fellow Council Member with American Association of Neuromuscular & Electrodiagnostic Medicine. Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a MS Mentorship Forum Participant with Foundation of the Consortium of Multiple Sclerosis Centers.
William Joseph Therriault Mr. Therriault has nothing to disclose.
Igal Mirman, MD Dr. Mirman has nothing to disclose.
Nada Ahmed, MD Dr. Ahmed has nothing to disclose.
Evrim Aksu-Menges Ms. Aksu-Menges has nothing to disclose.
Ayse Tulay Aydinoglu Ayse Tulay Aydinoglu has nothing to disclose.
Burcu Balci-Hayta Burcu Balci-Hayta has nothing to disclose.
Pascal Benkert Pascal Benkert has nothing to disclose.
Anna Bastiaansen Anna Bastiaansen has nothing to disclose.
Ahmed Chenna, PhD Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences.
Charles Malpas Charles Malpas has nothing to disclose.
Irina Podkorytova No disclosure on file
Nader Pouratian Nader Pouratian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Nader Pouratian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Nader Pouratian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sensoria Therapeutics. Nader Pouratian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BrainLab.
Sabine Schaedelin Sabine Schaedelin has nothing to disclose.
Aleksandra Maleska Maceski Aleksandra Maleska Maceski has nothing to disclose.
Maria Agustina Ruiz Yanzi, MD Dr. Ruiz Yanzi has nothing to disclose.
Daniel Horton Daniel Horton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Childhood Arthritis and Rheumatology Research Alliance. Daniel Horton has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology & Drug Safety. The institution of Daniel Horton has received research support from Danisco USA Inc. The institution of Daniel Horton has received research support from Childhood Arthritis and Rheumatology Research Alliance/Arthritis Foundation. Daniel Horton has received personal compensation in the range of $0-$499 for serving as a Consultant with US Food & Drug Administration. Daniel Horton has received personal compensation in the range of $500-$4,999 for serving as a Guideline Development Team Member, Speaker with American College of Rheumatology.
Nikolai Gil Diwa Reyes, MD Dr. Reyes has nothing to disclose.
Maria Laura Saladino Maria Laura Saladino has nothing to disclose.
Anna Castillo Anna Castillo has nothing to disclose.
Maria Alejandra Garcia-Dominguez, MD Dr. Garcia-Dominguez has nothing to disclose.
Sonia Padiglioni Sonia Padiglioni has nothing to disclose.
Lucas Scárdua Silva, MD Dr. Silva has nothing to disclose.
Cayla Vila, MD Dr. Vila has nothing to disclose.
Harjot Hansra, MD Dr. Hansra has nothing to disclose.
Katharine Dermigny, MD Dr. Dermigny has nothing to disclose.
Delini Sivakumar, MD Dr. Sivakumar has nothing to disclose.
Sean Thomas Beattie, DO Dr. Beattie has nothing to disclose.
Dana Most, MD, PhD Dr. Most has nothing to disclose.
Jonadab Dos Santos Silva Mr. Dos Santos Silva has nothing to disclose.
Jie Pan, MD Dr. Pan has nothing to disclose.
Mohammad Jamil Ahmad, MD Dr. Ahmad has nothing to disclose.
Neena Viswanathan, MD Dr. Viswanathan has nothing to disclose.
Gloria Isabel Ortiz Guerrero, MD Dr. Ortiz Guerrero has nothing to disclose.
Muhammad Khurram Afzal, MD Dr. Afzal has nothing to disclose.
Kalina Misiolek, MD Dr. Misiolek has nothing to disclose.
Austin Oblack, DO Dr. Oblack has nothing to disclose.
Shawn Michael Barton, MD, PhD Dr. Barton has nothing to disclose.
Matthew Feldman, MD Dr. Feldman has nothing to disclose.
Matthew Sontag Davitz, MD Dr. Davitz has nothing to disclose.
Fady Mousa-Ibrahim, DO Dr. Mousa-Ibrahim has nothing to disclose.
Donya Eizadkhah, MD Dr. Eizadkhah has nothing to disclose.
Jennifer Shoskes, PharmD No disclosure on file
Ashley Raedy, MD Dr. Raedy has nothing to disclose.
Bishow Chandra Mahat, MD Dr. Mahat has nothing to disclose.
Sanem Pinar Uysal, MD Dr. Uysal has nothing to disclose.
Olajide Abiola, MD Dr. Abiola has nothing to disclose.
Ailing Eileen Yang, MD Dr. Yang has nothing to disclose.
Julie K. Silver The institution of Dr. Silver has received research support from Binational Scientific Foundation. The institution of Dr. Silver has received research support from Arnold P Gold Foundation. Dr. Silver has received publishing royalties from a publication relating to health care.
Emma Dodd Emma Dodd has received personal compensation for serving as an employee of Roche Pharmaceuticals. Emma Dodd has stock in Roche Pharmaceuticals.
Yasodara Priyadharsi Senthamarai Siddharthan, MBBS Dr. Senthamarai Siddharthan has nothing to disclose.
Nanthaya Tisavipat, MD Miss Tisavipat has nothing to disclose.
Liane E. Hunter, MD, PhD Dr. Hunter has nothing to disclose.
Rosalind Mandelbaum, PA No disclosure on file
Shumaila Anwer, MD An immediate family member of Dr. Anwer has received personal compensation for serving as an employee of Southwest Airlines. Dr. Anwer has stock in Boeing.
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurelis, Alexza, Zogenix. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences. Enrique Carrazana has stock in Neurelis, Marinus, .
Hadi *Use 244643 Mohammad Khanli No disclosure on file
Marisa Whalen Marisa Whalen has received personal compensation for serving as an employee of Jazz Pharmaceuticals.
Mohammad Abughanam, MD Dr. Abughanam has nothing to disclose.
Tonse Ashwini Kini, MBBS Dr. Kini has nothing to disclose.
Nihal Satyadev, MD, MPH Mr. Satyadev has nothing to disclose.
Abeer Safan, MD Dr. Safan has nothing to disclose.
Yazan Nofal, MD Dr. Nofal has nothing to disclose.
Paul Daniel Crane, MD Dr. Crane has nothing to disclose.
Cheryl Fields, DO Dr. Fields has nothing to disclose.
Apirada Thongsing, MD Dr. Thongsing has nothing to disclose.
Conor T. Flavin, MD Dr. Flavin has nothing to disclose.
Talita D'Aguiar Rosa, MD Dr. D'Aguiar Rosa has nothing to disclose.
Erika Beth Chandler, MD Dr. Chandler has nothing to disclose.
Anooshah Ata, MD Dr. Ata has nothing to disclose.
Lara Carine Wadi, MD Dr. Wadi has nothing to disclose.
Mirasol Forcadela, MD Dr. Forcadela has nothing to disclose.
Kathryn Eszes, MD Dr. Eszes has nothing to disclose.
Abigail Suprova Bose, MD Dr. Bose has nothing to disclose.
Lamees H. Alzyoud, MD Dr. Alzyoud has nothing to disclose.
Ilana Lefkovitz, MD Dr. Lefkovitz has nothing to disclose.
Andy Tran Andy Tran has nothing to disclose.
Anna Pfalzer Anna Pfalzer has nothing to disclose.
Natalie Smith Ms. Smith has nothing to disclose.
Naoki Yamahara, MD Dr. Yamahara has nothing to disclose.
Frank Leypoldt, MD Frank Leypoldt, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Frank Leypoldt, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Frank Leypoldt, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Frank Leypoldt, MD has received research support from German Ministry of Education and Science . The institution of Frank Leypoldt, MD has received research support from German Research Council.
Akira Takekoshi Akira Takekoshi has nothing to disclose.
Samuel Matthew Jones, MD Dr. Jones has nothing to disclose.
Christopher Steven Mizenko Mr. Mizenko has nothing to disclose.
Maria Sol Román Maria Sol Román has nothing to disclose.
Yoonhyuk Jang Mr. Jang has nothing to disclose.
Helen Yin Zhou Ms. Zhou has received research support from The Barry Goldwater Scholarship and Excellence in Education Foundation.
Marie Charmaine Cootauco Sy, MD Marie Charmaine Sy has nothing to disclose.
José Ignacio Fernández Velasco José Ignacio Fernández Velasco has nothing to disclose.
Sabrina Bulancea Sabrina Bulancea has nothing to disclose.
Enric Monreal Enric Monreal has nothing to disclose.
Noelia Villarrubia Noelia Villarrubia has nothing to disclose.
Masako Matsunaga Masako Matsunaga has nothing to disclose.
Sarah Lewis Sarah Lewis has received stock or an ownership interest from Sarepta.
Annelly Buré-Reyes Annelly Buré-Reyes has nothing to disclose.
Boney Joseph Boney Joseph has nothing to disclose.
Caroline Pot Caroline Pot has nothing to disclose.
Erica Weiss The institution of Erica Weiss has received research support from NIH. The institution of Erica Weiss has received research support from NY State Dept of Health.
Abbey Staugaitis Abbey Staugaitis has nothing to disclose.
Emilio Villanueva III Emilio Villanueva III has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabX Corporation.
Hanna Joensen Hanna Joensen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Seth Margolis Seth Margolis has nothing to disclose.
Evelyn Lazar, MD Dr. Lazar has nothing to disclose.
Rachael Potter Rachael Potter has received stock or an ownership interest from Sarepta Therapeutics.
Tejdip Singh Tejdip Singh has received personal compensation for serving as an employee of Sarepta Therapeutics . Tejdip Singh has received stock or an ownership interest from Sarepta Therapeutics.
Urs Martin Fischer, MD, PA The institution of Urs Fischer has received research support from Medtronic. The institution of Urs Fischer has received research support from Medtronic.
Jonathan Carlson Jonathan Carlson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medtronic.
Akinyemi Ajayi Akinyemi Ajayi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceutical. Akinyemi Ajayi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceutical.
Joseph Volpe, PhD Dr. Volpe has received personal compensation for serving as an employee of Labcorp.
Laurie Gutmann No disclosure on file
Moises Garces Redondo, MD Mr. Garces Redondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Garces Redondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Mr. Garces Redondo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Almirall. Mr. Garces Redondo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Ana María Alonso Torres, MD Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Lucienne Costa Costa-Frossard Franca, Sr., PhD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biopas. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristoll-Mayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Maria Eugenia Balbuena Mrs. Balbuena has nothing to disclose.
Jesus Manuel Martin Martinez Jesus Manuel Martin Martinez has nothing to disclose.
Jennifer Gudeman Miss Gudeman has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Miss Gudeman has stock in Avadel Pharmaceuticals.
Enric Monreal Laguillo Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb.
Mariona Hervas Pujol Mariona Hervas Pujol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Merk, Bayer, Biogen, Almirall.
Claire Bridel Claire Bridel has nothing to disclose.
Jalyce Taylor Miss Taylor has nothing to disclose.
Sadia Nishat, MBBS, FCPS Dr. Nishat has nothing to disclose.
Stefano Malerba, MD Dr. Malerba has nothing to disclose.
Mac DeHart-McCoyle, DO Dr. DeHart-McCoyle has nothing to disclose.
Doris Xia, DO Dr. Xia has nothing to disclose.
Marie Varnet, MD Dr. Varnet has nothing to disclose.
Eleni Drakou, MD Dr. Drakou has nothing to disclose.
Nathan Morelli, PhD,PT Dr. Morelli has received personal compensation for serving as an employee of Medtronic.
Michael Andrew Witt, MD Dr. Witt has nothing to disclose.
Amna Amad Siddiqui, MBBS Dr. Siddiqui has nothing to disclose.
Ahmed Mohamed Taha Abdelhak, MD The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society.
Priya Nidamanuri, MD Dr. Nidamanuri has nothing to disclose.
Sarah Shapiro Miss Shapiro has nothing to disclose.
Gina Marina Andraos, MD Dr. Andraos has nothing to disclose.
Diana Alejandra Madrid, MS Miss Madrid has received personal compensation in the range of $10,000-$49,999 for serving as a Grantee with Institute of Internation Education. Miss Madrid has received personal compensation in the range of $500-$4,999 for serving as a Early Investigator Travel Award with American Society for Bone and Mineral Research. Miss Madrid has received personal compensation in the range of $0-$499 for serving as a Travel Award with American Neurological Association.
Nicole Walsh, NP Mrs. Walsh has nothing to disclose.
Saketh Annam, MBBS Dr. Annam has nothing to disclose.
Thomas Patrick Stern, MD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel Pharmaceutical. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care.
Tyler Lee Borko, BA, EMT-IV Mr. Borko has nothing to disclose.
John Harsh, PhD Dr. Harsh has nothing to disclose.
Keiko Higuchi, Other Miss Higuchi has received personal compensation for serving as an employee of Sanofi. Miss Higuchi has received personal compensation for serving as an employee of Novartis. Miss Higuchi has received personal compensation for serving as an employee of Gilead Sciences . Miss Higuchi has received personal compensation for serving as an employee of Pfizer Inc. . Miss Higuchi has received personal compensation for serving as an employee of Zynx Health Inc. . Miss Higuchi has received stock or an ownership interest from Sanofi. Miss Higuchi has received stock or an ownership interest from Gilead. Miss Higuchi has received stock or an ownership interest from Novartis.
Alexander James Gillespie Mr. Gillespie has nothing to disclose.
Rami Ben-Joseph, PhD Dr. Ben-Joseph has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Ben-Joseph has stock in Jazz Pharmaceuticals.
Wayne Macfadden, MD,PT Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma.
Valentina Moschini, Neuropsychologist Miss Moschini has nothing to disclose.
Marina Sarno, Other Dr. Sarno has nothing to disclose.
Elizabeth C. Dabrowski, Jr., Other Ms. Dabrowski has received personal compensation for serving as an employee of Aetion, Inc.. Ms. Dabrowski has received stock or an ownership interest from AbbVie Inc.. Ms. Dabrowski has received stock or an ownership interest from BioMarin Pharmaceutical Inc.. Ms. Dabrowski has received stock or an ownership interest from CVS Health Corporation . Ms. Dabrowski has received stock or an ownership interest from Moderna Inc.. Ms. Dabrowski has received stock or an ownership interest from Walgreens Boots Alliance.
Ragy Saad, Other Mr. Saad has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Saad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidinno Outcomes Research Inc.. Mr. Saad has received stock or an ownership interest from Jazz Pharmaceuticals.
Laura Borrega Canelo, Sr., MD Dr. Borrega Canelo has nothing to disclose.
Silvia Bagnoli, PhD Dr. Bagnoli has nothing to disclose.
Francisco Barrero-Hernandez, Sr., MD Dr. Barrero-Hernandez has nothing to disclose.
Jennifer *Use 325910 Shoskes, PharmD Dr. Shoskes has received personal compensation for serving as an employee of Fulcrum Therapeutics. An immediate family member of Dr. Shoskes has received personal compensation for serving as an employee of Exact Science.
Giulia Galdo, MD Dr. Galdo has nothing to disclose.
Maria Teresa De Cristofaro, MD Dr. De Cristofaro has nothing to disclose.
Gabaldon Torres Laura, Jr., Other Mrs. Laura has nothing to disclose.
Dayana Rodriguez, PhD Dr. Rodriguez has nothing to disclose.
Scott Harcourt, PhD Dr. Harcourt has nothing to disclose.
Solmaz Ramezani Hashtjin, MD Dr. Ramezani Hashtjin has nothing to disclose.
Olga Carmona, MD Dr. Carmona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK. Dr. Carmona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BIOGEN .
Javier *Use 290687 Sotoca, MD Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Mr. Sotoca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Ashley A. Weaver, PhD Dr. Weaver has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elemance, LLC. Dr. Weaver has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for KLS Martin. The institution of Dr. Weaver has received research support from KLS Martin. The institution of Dr. Weaver has received research support from Toyota. The institution of Dr. Weaver has received research support from NASA. The institution of Dr. Weaver has received research support from NHTSA. The institution of Dr. Weaver has received research support from NIH. The institution of Dr. Weaver has received research support from NSF. The institution of Dr. Weaver has received research support from RCCADS.
Connor Goo Mr. Goo has nothing to disclose.
Madeleine Diepman Ms. Diepman has nothing to disclose.
Rebecca Knapp Ms. Knapp has nothing to disclose.
Erin DeSpain Ms. DeSpain has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Bio Solutions.
Jingxiao Zhang Dr. Zhang has nothing to disclose.
Kameron Bates, Other Mr. Bates has nothing to disclose.
Neha Atulkumar Singh, PhD Dr. Singh has nothing to disclose.
Kelly Marshall Ms. Marshall has nothing to disclose.
Talia Brianna Feldman, Other Ms. Feldman has nothing to disclose.
Janice Convoy-Hellmann, Other Ms. Hellmann has nothing to disclose.
John Jiang, PhD Dr. Jiang has received personal compensation for serving as an employee of Fulcrum Therapeutics.
Nicol Voermans, MD The institution of Mrs. Voermans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynacure. The institution of Mrs. Voermans has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Mrs. Voermans has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromuscular disorder.
Lara Bardoneschi, Other Miss Bardoneschi has nothing to disclose.
Chun-Yen Cheng, Other Mr. Cheng has received personal compensation for serving as an employee of Bristol Myers Squibb. Mr. Cheng has stock in Bristol Myers Squibb.
Loana De Los Santos, Jr., Other Mrs. De Los Santos has nothing to disclose.
Lindsay Tetreault, MD, PhD Dr. Tetreault has nothing to disclose.
Markus Karlsson, PhD Dr. Karlsson has received personal compensation for serving as an employee of AMRA Medical.
Joost Kools, MD The institution of Mr. Kools has received research support from Fulcrum Therapeutics.
Maitea Guridi, PhD Dr. Guridi has received personal compensation for serving as an employee of Hoffmann-La Roche.
Han *Use 381183 Xie, Other Miss Xie has nothing to disclose.
Britney Barrera Ms. Barrera has nothing to disclose.
Eunnindy Dells Sanon, Other Ms. Sanon has received personal compensation for serving as an employee of Brigham and Women's Hospital .
Shayan Khan, Other Dr. Khan has nothing to disclose.
Abby Chen, Other Ms. Chen has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Ms. Chen has received stock or an ownership interest from Jazz Pharmaceuticals.
Jessica Saurman, PhD Dr. Saurman has nothing to disclose.
David Watson, PhD Dr. Watson has nothing to disclose.
Cynthia Zheng, MD Ms. Zheng has nothing to disclose.
James A. Town, MD Dr. Town has nothing to disclose.
David Weintraub, MD Dr. Weintraub has nothing to disclose.
Fiadhnait O'Keeffe, PhD Dr. O'Keeffe has nothing to disclose.
Sanita Raju, MD Dr. Raju has nothing to disclose.
Sumeet Vadera, MD Dr. Vadera has nothing to disclose.
Brooke L. Valdez, Other Ms. Valdez has a non-compensated relationship as a Valdez with The Rocky Mountain MS Center non-profit partner that is relevant to AAN interests or activities.
Grace Elizabeth Vitek, MD Ms. Vitek has nothing to disclose.
Eduardo Inacio Nascimento Andrade, MD Dr. Nascimento Andrade has nothing to disclose.
Robert Bonow Robert Bonow has nothing to disclose.
Jyoti Malhotra Jyoti Malhotra has nothing to disclose.
Chiara Robba No disclosure on file
Mary St. Romain Mary St. Romain has nothing to disclose.
Meredith M. Miller Mrs. Miller has received personal compensation for serving as an employee of Emalex Biosciences. Mrs. Miller has stock in Emalex Biosciences.
Soo Hwan Park Mr. Park has nothing to disclose.
David J. Kim, Other Mr. Kim has received personal compensation for serving as an employee of Emalex Biosciences.
Stephanie Victoria Meier Miss Meier has nothing to disclose.
Lester Melie-Garcia, PhD Dr. Melie-Garcia has nothing to disclose.
Eline AJ Willemse, PhD Dr. Willemse has nothing to disclose.
Johanna Oechtering, MD The institution of Dr. Oechtering has received research support from Swiss MS Society.
Muhamed Barakovic, PhD Mr. Barakovic has nothing to disclose.
Riccardo Galbusera, MD Dr. Galbusera has nothing to disclose.
Nancy Lynn, Other Ms. Lynn has nothing to disclose.
Clare Elise Schrodt, MD Ms. Schrodt has nothing to disclose.
Aafreen Khan, MD Dr. Khan has nothing to disclose.
Lea Saab Miss Saab has nothing to disclose.
Alberto Rafael Aguirre, MD Dr. Aguirre has nothing to disclose.
Sergio Muniz-Castrillo, MD, PhD Dr. Muniz-Castrillo has nothing to disclose.
Yadi Li Ms. Li has nothing to disclose.
Alanna Marie Ritchie Mrs. Ritchie has nothing to disclose.
Maayan Joy Yakir, MD Dr. Yakir has nothing to disclose.
Manasa Sudheendra, MBBS Dr. Sudheendra has nothing to disclose.
Stephanie Hsinyun Chen, MD Dr. Chen has nothing to disclose.
Shlok Sarin Mr. Sarin has nothing to disclose.
Su Htet Htet Naing, MD Ms. Naing has nothing to disclose.
Soonmyung Hwang Mr. Hwang has nothing to disclose.
Sama Noroozi Gilandehi, MD Dr. Noroozi Gilandehi has nothing to disclose.
Rachel Hunsucker Ms. Hunsucker has nothing to disclose.
Saskia Raeuber, MD Dr. Raeuber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Healthcare Germany GmbH. The institution of Dr. Raeuber has received research support from Stiftung zur Förderung junger Neurowissenschaftler. The institution of Dr. Raeuber has received research support from Novartis.
Sabrina Hickle, PhD Dr. Hickle has nothing to disclose.
Shaima Mudather Elsheikh, MBBS Dr. Elsheikh has nothing to disclose.
Rayan Salah Ahmed Hassan, PhD Dr. Hassan has nothing to disclose.
Nadir Galal Abdelrahman, MD Dr. Abdelrahman has nothing to disclose.
Asma Mustafa, MBBS Dr. Mustafa has nothing to disclose.
Duaa Nasereldin, MBBS Dr. Nasereldin has nothing to disclose.
Maya Advani, MBBS Mrs. Advani has nothing to disclose.
Eiman Dai, MBBS Dr. Dai has nothing to disclose.
Amal Abdelkarim Alamin, MBBS Dr. Alamin has nothing to disclose.
Mayra Mezzoni, MD Dr. Mezzoni has nothing to disclose.
Christina Barbara Schroeter, MD Dr. Schroeter has nothing to disclose.
Khaled Ghoniem, MD Dr. Ghoniem has nothing to disclose.
Soha Rida Freidy, Other Dr. Freidy has received personal compensation for serving as an employee of Allucent.
Sajeevan Sujanthan Mr. Sujanthan has nothing to disclose.
Caio Pluvier Duarte Costa Mr. Costa has nothing to disclose.
Teodora Pene Dumitrescu, PhD Dr. Pene Dumitrescu has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allucent. Dr. Pene Dumitrescu has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TEVA Pharmaceutics. Dr. Pene Dumitrescu has stock in GlaxoSmithkline.
Virginia D. Schmith, PhD Dr. Schmith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Emalex Biosciences. Dr. Schmith has received research support from Emalex BIosciences.
Anne Marie Morse, DO,Other The institution of Dr. Morse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals, Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceuticals, Alkermes, National Institute for Health, and Geisinger Health Plan. The institution of Dr. Morse has received research support from Harmony Biosciences, Avadel Pharmaceuticals, Takeda Pharmaceuticals, Alkermes, National Institute for Health, and Geisinger Health Plan.
Jenny Madsen, Other Ms. Madsen has received personal compensation for serving as an employee of The Huntington's Disease Society of America.
Margaret Gerbasi, PhD Ms. Gerbasi has received personal compensation for serving as an employee of Sage Therapeutics, Inc.. Ms. Gerbasi has stock in Sage Therapeutics. Ms. Gerbasi has received intellectual property interests from a discovery or technology relating to health care.
Bradley Collier, PhD Dr. Collier has received personal compensation for serving as an employee of Labcorp. Dr. Collier has stock in Labcorp.
Sally Ibrahim, MD The institution of Dr. Ibrahim has received research support from Avadel. The institution of Dr. Ibrahim has received research support from NIH.
Rioghna R. Pittock An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc.. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. An immediate family member of Miss Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann/LaRoche AG. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann/LaRoche. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of an immediate family member of Miss Pittock has received research support from Grifols. The institution of an immediate family member of Miss Pittock has received research support from NIH. The institution of an immediate family member of Miss Pittock has received research support from Viela Bio.MedImmune/Horizon. The institution of an immediate family member of Miss Pittock has received research support from Alexion Pharmaceuticals. The institution of an immediate family member of Miss Pittock has received research support from F. Hoffmann/LaRoche/Genentech. An immediate family member of Miss Pittock has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Miss Pittock has received intellectual property interests from a discovery or technology relating to health care.
Sara Paredes-Echeverri, MD Dr. Paredes-Echeverri has nothing to disclose.
Triet Vo, Other Mr. Vo has nothing to disclose.
Sean Bradley Woods Mr. Woods has nothing to disclose.
Ashley Harrie Ms. Harrie has nothing to disclose.
Hani Atamna, PhD Dr. Atamna has nothing to disclose.
Matthew Tae Mr. Tae has nothing to disclose.
Emily Herreshoff, Other Ms. Herreshoff has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Huxley Medical Inc.
Benjamin Hampstead The institution of Dr. Hampstead has received research support from NIH. The institution of Dr. Hampstead has received research support from Department of Veterans Affairs. Dr. Hampstead has received intellectual property interests from a discovery or technology relating to health care. Dr. Hampstead has received publishing royalties from a publication relating to health care.
Emily Spoth, Other Ms. Spoth has stock in Applied Genetic Technologies Corporation. Ms. Spoth has stock in MeiraGTx Holdings. Ms. Spoth has stock in Ocugen. Ms. Spoth has stock in PTC Therapeutics.
Gabriel Monteiro Salvador, Other Mr. Salvador has received research support from The Research Support Foundation of the State of São Paulo.
Angela T.H. Kwan, MSc Miss Kwan has nothing to disclose.
Rinako Nakayama, Other Ms. Nakayama has nothing to disclose.
Kan Xu, Other Mr. Xu has received personal compensation for serving as an employee of Jazz Pharmaceuticals Inc.
Trieste Francis Miss Francis has nothing to disclose.
Kazuyoshi Togashi Dr. Togashi has nothing to disclose.
Shin Chang Ms. Chang has nothing to disclose.
Derek Martinez, MD Dr. Martinez has nothing to disclose.
Mohamed Elminawy, MD Dr. Elminawy has nothing to disclose.
Russell Grant, PhD Dr. Grant has received personal compensation for serving as an employee of Labcorp.
Andrew John Guthrie Mr. Guthrie has nothing to disclose.
Jenna Okazaki Miss Okazaki has nothing to disclose.
Donovan Roy Mr. Roy has nothing to disclose.
Plyfaa Suwanamalik-Murphy Ms. Suwanamalik-Murphy has nothing to disclose.
Alisia Southwell Mrs. Southwell has nothing to disclose.
Jongmok Ha, MD Dr. Ha has nothing to disclose.
Abdolreza Siadati, MD Dr. Siadati has nothing to disclose.
Derval McCormack, Other Miss McCormack has nothing to disclose.
Min Cheol Song, MD Dr. Song has nothing to disclose.
Shweta Kalita Mrs. Kalita has nothing to disclose.
Annie Ziyi He Ms. He has nothing to disclose.
Sushma Gandham, Other Ms. Gandham has nothing to disclose.
Matthew Halber, Other Mr. Halber has nothing to disclose.
Firoza Zubeida Lussier, Other Miss Lussier has nothing to disclose.
Rocío Gómez, Other Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department.
Zahra Azizi, MD Dr. Azizi has nothing to disclose.
Nesrine Rahmouni, Other Ms. Rahmouni has nothing to disclose.
Andre Valcour Dr. Valcour has nothing to disclose.
Vanessa Pallen, Other Miss Pallen has nothing to disclose.
Craig Jeffrey Pfister, Other Mr. Pfister has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Pfister has stock in Jazz Pharmaceuticals.
Carmen Morinelli Miss Morinelli has nothing to disclose.
Saman Arfaie, Other Mr. Arfaie has nothing to disclose.
Luis Rafael Solís-Tarazona, MD Mr. Solís-Tarazona has received personal compensation for serving as an employee of Novo Nordisk A/S.
Skarleth Cardenas Romero, Jr., MD Mrs. Cardenas Romero has nothing to disclose.
Rongyi *use 384703 Sun Ms. Sun has nothing to disclose.
Kwanghoon Lee, Other Mr. Lee has nothing to disclose.
Jonathan Alexander Hermel, MD Dr. Hermel has nothing to disclose.
Drushti Deepak Birwatkar Miss Birwatkar has nothing to disclose.
Taeeun Kyung, MD Dr. KYUNG has nothing to disclose.
Kihoon Bae, MD Dr. Bae has nothing to disclose.
Kwang June Lee, MD Dr. Lee has nothing to disclose.
Hyunwook Kang, MD Dr. Kang has nothing to disclose.
Dong Kyu Kim, MD Dr. Kim has nothing to disclose.
Jong Rho, MD Dr. Rho has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Rho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nutricia. Dr. Rho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerecin. Dr. Rho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Rho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Rho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. Dr. Rho has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. The institution of Dr. Rho has received research support from National Institutes of Health. Dr. Rho has received publishing royalties from a publication relating to health care.
Hyeonjoon Kim, MD Dr. KIM has nothing to disclose.
Euiho Lee, MD Dr. Lee has nothing to disclose.
Thomas James Paxton, II Mr. PAXTON has nothing to disclose.
Zeba Noorain, MBBS Dr. Noorain has nothing to disclose.
Julie Hviid Hahn-Pedersen Mrs. Hviid Hahn-Pedersen has received personal compensation for serving as an employee of Novo Nordisk A/S. Mrs. Hviid Hahn-Pedersen has stock in Novo Nordisk.
Juliette Brenner, MD Ms. Brenner has nothing to disclose.
Chiara Rocchi, MD Dr. Rocchi has nothing to disclose.
Jenna Stevenson, Other Miss Stevenson has nothing to disclose.
Samantha Walsh, Other Ms. Walsh has nothing to disclose.
Cecile Tissot Mrs. Tissot has nothing to disclose.
Brian Chiluba, Other Dr. Chiluba has nothing to disclose.
Emily Ann Stone, Other Miss Stone has received personal compensation for serving as an employee of Mightier. Miss Stone has stock in Mightier.
Krista Lanctot Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel Therapeutics. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bright Minds. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel Therapeutics. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Co. Ltd. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Exciva. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ICG Pharma. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kondor Pharma. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for H Lundbeck A/S. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Therapeutics. Prof. Lanctot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo Pharma Co. Ltd. Prof. Lanctot has stock in Highmark Interactive.
Jay Panicker, MD,MBBS,Other Dr. Panicker has nothing to disclose.
Eddie Darton, MD Dr. Darton has received personal compensation for serving as an employee of Sarepta Therapeutics. Dr. Darton has stock in Sarepta Therapeutics.
Jessica Ragnio, Other Ms. Ragnio has received personal compensation for serving as an employee of Mightier. Ms. Ragnio has stock in Mightier.
Lixi Yu Mrs. Yu has nothing to disclose.
James Antony Richardson, MBBS Dr. Richardson has received personal compensation for serving as an employee of Sarepta Therapeutics. Dr. Richardson has stock in Sarepta Therapeutics.
Wojciech Michalak Mr. Michalak has received personal compensation for serving as an employee of Novo Nordisk.
Jordan Bontrager, Other Ms. Bontrager has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Muscular Dystrophy Association.
Tucker Harvey Mr. Harvey has nothing to disclose.
Yvette Crijnen, MD Ms. Crijnen has nothing to disclose.
Elizabeth Stone Smith, PhD Dr. Smith has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc. Dr. Smith has stock in Sarepta Therapeutics.
Stijn Servaes Dr. Servaes has nothing to disclose.
Robert Blake Buchalter, PhD Dr. Buchalter has stock in Pfizer Inc. Dr. Buchalter has stock in Viatris Inc. Dr. Buchalter has received personal compensation in the range of $100,000-$499,999 for serving as a Predoctoral and Postdoctoral Trainee with NIH.
Christian Wichmann Dr. Wichmann has received personal compensation for serving as an employee of Novo Nordisk.
Oscar Harari, PhD Dr. Harari has nothing to disclose.
Shervin Rahimpour, MD Dr. Rahimpour has nothing to disclose.
Cynthia Saiontz-Martinez, Other Ms. Saiontz-Martinez has nothing to disclose.
Alyssa L. Peechatka, PhD Dr. Peechatka has received personal compensation for serving as an employee of Mightier. Dr. Peechatka has stock in Mightier. The institution of Dr. Peechatka has received research support from National Institutes of Mental Health .
Niko Nykanen, PhD Dr. Nykanen has nothing to disclose.
Lars Lau L. Raket, PhD Dr. Raket has received personal compensation for serving as an employee of Novo Nordisk A/S. Dr. Raket has received personal compensation for serving as an employee of Lundbeck.
Charles Gordon Mr. Gordon has received personal compensation for serving as an employee of LivaNova. Mr. Gordon has stock in LivaNova.
Sariya Udayachalerm, PhD Dr. Udayachalerm has nothing to disclose.
Seo Ho Song, MD,PhD Dr. Song has nothing to disclose.
Sidish Venkataraman, MD Dr. Venkataraman has nothing to disclose.
Aidan Power, PhD Dr. Power has received personal compensation for serving as an employee of Alzheon. Dr. Power has stock in Pfizer. Dr. Power has stock in Alzheon.
Elizabeth Chertavian, Other Mrs. Chertavian has nothing to disclose.
Michal Tzadok, MD Dr. Tzadok has nothing to disclose.
Mira Chamoun, PhD Dr. Chamoun has nothing to disclose.
John Jarvis, Other Mr. Jarvis has nothing to disclose.
Gleb Bezgin Dr. Bezgin has nothing to disclose.
Jason Kahn, PhD Dr. Kahn has received personal compensation for serving as an employee of Neuromotion Labs. Dr. Kahn has stock in Neuromotion Labs. The institution of Dr. Kahn has received research support from NIMH. Dr. Kahn has received intellectual property interests from a discovery or technology relating to health care.
Zachary James Smith, PhD Dr. Smith has nothing to disclose.
Abdallah M. Eteleeb, PhD Dr. Eteleeb has nothing to disclose.
Mareike Jansen, Other Miss Jansen has nothing to disclose.
Juna Marcella De Vries, MD,PhD The institution of Dr. De Vries has received research support from 2021 AEA Community Seed Grant.
J Emer MacSweeney, MD Dr. MacSweeney has nothing to disclose.
Sriram Shankar, PhD Dr. Shankar has received personal compensation for serving as an employee of Biogen. Dr. Shankar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trinity Lifesciences, Triangle Insights Group. Dr. Shankar has stock in Biogen. Dr. Shankar has stock in Multiple Biotech Companies.
Helen Latimer, Other Ms. Latimer has received personal compensation for serving as an employee of Aetion. Ms. Latimer has stock in Aetion.
Clark Jackson Ms. Jackson has received personal compensation for serving as an employee of Aetion. Ms. Jackson has stock in Aetion.
Nida Jasmein Ahmed Ms. Ahmed has nothing to disclose.
Sara Gil-Perotin, MD,PhD Dr. Gil-Perotin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Tiffany Boyd, RN Mrs. Boyd has nothing to disclose.
Bilal Haque, Other Mr. Haque has nothing to disclose.
Ralph Dagostino, Jr., PhD Dr. Dagostino has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Dagostino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Dagostino has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exelixis. Dr. Dagostino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MEI Pharma. Dr. Dagostino has received research support from NIH.
Katherine Mues, PhD Dr. Mues has received personal compensation for serving as an employee of Aetion.
Weiyi Ni, PhD Dr. Ni has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Ni has stock in Jazz Pharmaceuticals.
Richard Cui, PhD Dr. Cui has nothing to disclose.
Louis Faust, PhD Dr. Faust has nothing to disclose.
Carolyn Langlois, Other Ms. Langlois has received personal compensation for serving as an employee of Banner Alzheimer's Institute.
María Del Pilar Perachino, MD Miss Perachino has nothing to disclose.
Michael Nolan Cook, PhD Dr. Cook has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Cook has stock in Jazz Pharmaceuticals.
Amelia Bartolomeo Ms. Bartolomeo has nothing to disclose.
Juan Ignacio Cao, MD Dr. Cao has nothing to disclose.
Nana Keita Fofana, PA Mrs. Fofana has nothing to disclose.
Ryan Fischer Mr. Fischer has received personal compensation for serving as an employee of Parent Project Muscular Dystrophy.
Beom Seuk Hwang, PhD Dr. Hwang has nothing to disclose.
Xiaolan Zhang, Other Mrs. Zhang has nothing to disclose.
Debasree Banerjee, MD Dr. Banerjee has nothing to disclose.
Cade Michael Haynie Mr. Haynie has nothing to disclose.
Maureen McGuirk Sampson, PhD The institution of Dr. Sampson has received research support from NIH NIEHS K00. The institution of Dr. Sampson has received research support from Burroughs Wellcome Fund PDEP. The institution of an immediate family member of Dr. Sampson has received research support from Parkinsons Foundation. The institution of an immediate family member of Dr. Sampson has received research support from Parkinsons Foundation Stanley Fahn. The institution of an immediate family member of Dr. Sampson has received research support from ASAP Collab Network. The institution of an immediate family member of Dr. Sampson has received research support from NIEHS. An immediate family member of Dr. Sampson has received intellectual property interests from a discovery or technology relating to health care.
Monica Saray Rodriguez Rodríguez, Sr., MD Dr. Rodríguez has nothing to disclose.
Steven Sloan, PhD,MD Dr. Sloan has nothing to disclose.
Florencia Micaela Daniele Miss Daniele has nothing to disclose.
Breanna Chachere Ms. Chachere has nothing to disclose.
Diana Sarai Lopez Gonzalez Dr. Lopez Gonzalez has nothing to disclose.
Alexia King, Other Ms. King has nothing to disclose.
Jasmine W. Jiang Ms. Jiang has nothing to disclose.
Xiaojing Peng Ms. Peng has nothing to disclose.
Steve Simpson-Yap, PhD Dr. Simpson-Yap has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis and Related Disorders. Dr. Simpson-Yap has received personal compensation in the range of $500-$4,999 for serving as a Grant Assessment Committee Member with Medical Research Future Fund . Dr. Simpson-Yap has a non-compensated relationship as a Associate Editor with Frontiers in Neurology that is relevant to AAN interests or activities.
Enrico Bergamin, MD Dr. Bergamin has nothing to disclose.
Annette Orleth Dr. Orleth has nothing to disclose.
Ulrike Schara Schmidt, MD Prof. Schara Schmidt has received personal compensation for serving as an employee of PTC. Prof. Schara Schmidt has received personal compensation for serving as an employee of Pfizer. Prof. Schara Schmidt has received personal compensation for serving as an employee of Sarepta. Prof. Schara Schmidt has received personal compensation for serving as an employee of Roche. Prof. Schara Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Prof. Schara Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Schara Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Prof. Schara Schmidt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Schara Schmidt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sarepta.
Matias Viitala, Other Mr. Viitala has nothing to disclose.
Janne Mannseth, PhD Miss Mannseth has nothing to disclose.
Alessandro Cagol, MD Dr. Cagol has nothing to disclose.
William B. White, MD Dr. White has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for JAZZ Pharmaceuticals.
Kemi Bankole, MBBS Dr. Bankole has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Bankole has stock in Sage Therapeutics.
Joshua Ray Tanzer Dr. Tanzer has nothing to disclose.
Namoh Kim, MD Mr. Kim has nothing to disclose.
Michael Jaworski III, Other Mr. Jaworski III has nothing to disclose.
Maria Vlasaty, Other Mrs. Vlasaty has nothing to disclose.
Juan Luis Chico-Garcia, MD Dr. Chico-Garcia has received personal compensation in the range of $0-$499 for serving as a Consultant for BIAL. Dr. Chico-Garcia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for SANOFI.
Rochelle Rosen, PhD Dr. Rosen has nothing to disclose.
Claudia Nuti, Sr., Other Miss Nuti has nothing to disclose.
Ryan Lantini Mr. Lantini has nothing to disclose.
Anna Hernandez Ms. Hernandez has nothing to disclose.
Ellen PPMD Ms. PPMD has received personal compensation for serving as an employee of Parent Project Muscular Dystrophy.
Julia Pitino Miss Pitino has received personal compensation for serving as an employee of Aetion, Inc. Miss Pitino has stock in Aetion, Inc.
Adrienne James Ms. JAMES has nothing to disclose.
Kennedi Wilson, Other Miss Wilson has nothing to disclose.
Ashlynn Mills Mrs. Mills has nothing to disclose.
Anson Sing, PhD Mr. Sing has nothing to disclose.
Abhijit Lele, MD,MBBS,Other Dr. Lele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LifeCenter Northwest .
Jinyoung Youn, MD,PhD Prof. Youn has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medtronic. Prof. Youn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. Prof. Youn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. Prof. Youn has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Myung-In Pharm. Prof. Youn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. Prof. Youn has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai Co. Ltd. Prof. Youn has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for SK Chem.
Laura Bennett, PhD Dr. Bennett has stock in Bristol Myers Squibb. Dr. Bennett has stock in Merck. Dr. Bennett has stock in Cigna. Dr. Bennett has stock in Organon.
Cheol Lee, MD,PhD Dr. Lee has nothing to disclose.
Jason Roy, Jr. Dr. Roy has nothing to disclose.
Kyung Il Park, MD,PhD Prof. Park has nothing to disclose.
James B. Ford, DO Dr. Ford has nothing to disclose.
Fernando Rodriguez Jorge, PhD Dr. Rodriguez Jorge has received personal compensation in the range of $0-$499 for serving as a Consultant for Bial. Dr. Rodriguez Jorge has received personal compensation in the range of $0-$499 for serving as a Consultant for Sanofi.
Roshani Patel Miss PATEL has nothing to disclose.
Suyeon Park, Other Ms. Park has nothing to disclose.
Elena Natera-Villalba, MD Mrs. NATERA-VILLALBA has received research support from Sociedad Española de Neurologia.
Gloria Contreras, Other Ms. Contreras has nothing to disclose.
John A. Hey, PhD Dr. Hey has received personal compensation for serving as an employee of Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has received intellectual property interests from a discovery or technology relating to health care.
Earvin Liang, PhD Dr. Liang has received personal compensation for serving as an employee of Alzheon.
Sachit Patel, MD Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sobi Inc.
Amanda Puckett Miss Puckett has nothing to disclose.
Marina Martinez Sanchez, MD Mrs. Martinez Sanchez has nothing to disclose.
Yuka Atagi Martens, PhD Dr. Martens has nothing to disclose.
Kunhee Park, MD,PhD Dr. Park has nothing to disclose.
Salma Reddam No disclosure on file
Tetsuya Ioku, MD Dr. Ioku has nothing to disclose.
Stefanie Mason, MD Dr. Mason has received personal compensation for serving as an employee of Sarepta. Dr. Mason has stock in Sarepta. An immediate family member of Dr. Mason has stock in Sarepta. The institution of an immediate family member of Dr. Mason has received research support from Biogen. The institution of Dr. Mason has received research support from NIH. The institution of Dr. Mason has received research support from Chest Foundation.
Jannice Roeser Ms. Roeser has nothing to disclose.
Antonio De Cesare Del Nero, Other Mr. De Cesare Del Nero has received research support from Universidade Estadual de Campinas.
Riem El Tahry, MD The institution of Prof. Tahry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. The institution of Prof. Tahry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Livanova. The institution of Prof. Tahry has received research support from Livanova.
Santiago Isa, MD Dr. Isa has nothing to disclose.
Catherine R. Jay, MD Dr. Jay has nothing to disclose.
Nina Grytten, PhD Dr. Grytten has nothing to disclose.
Mónica Borges Guerra, Other Mrs. Borges Guerra has nothing to disclose.
Susanne Ostrowitzki Dr. Ostrowitzki has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Ostrowitzki has stock in F. Hoffmann-La Roche Ltd.
Todd Kirby, PhD Dr. Kirby has received personal compensation for serving as an employee of Jazz Pharmaceuticals, Inc. Dr. Kirby has stock in Jazz Pharmaceuticals, Inc..
Fiona Rose Mrs. Rose has received personal compensation for serving as an employee of Roche. Mrs. Rose has stock in Roche .
Rachel Schrader, NP Mrs. Schrader has nothing to disclose.
Alexander Peter Murphy, PhD,MBBS Dr. Murphy has nothing to disclose.
Mark Sands, PhD Prof. Sands has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for M6P Therapeutics. Prof. Sands has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amicus. Prof. Sands has stock in JAYA Biosciences. The institution of Prof. Sands has received research support from JAYA Biosciences. Prof. Sands has received intellectual property interests from a discovery or technology relating to health care.
Tobias Gerhard, PhD Dr. Gerhard has nothing to disclose.
Lilly East, PhD Mrs. East has received personal compensation for serving as an employee of Sarepta Therapeutics.
Marie Sutherland Nunez, Other Ms. Nunez has nothing to disclose.
Damon Asher, PhD Mr. Asher has received personal compensation for serving as an employee of Sarepta Therapeutics. Mr. Asher has stock in Sarepta Therapeutics.
Arenn Faye Carlos, MD Dr. Carlos has nothing to disclose.
Alyssa Westring Dr. Westring has nothing to disclose.
JaeKyung Won, Sr. Prof. Won has nothing to disclose.
Bradley McDaniels, PhD Dr. McDaniels has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NeuroChallenge.
Abner Nyandege, PhD Dr. Nyandege has nothing to disclose.
Marco Hermesdorf Dr. Hermesdorf has nothing to disclose.
Debora Nadur, Sr., MD Dr. Nadur has nothing to disclose.
Erin Kross, MD Dr. Kross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for A PCORI funded grant. The institution of Dr. Kross has received research support from NIH.
Soo Hyun Ahn, MD Dr. Ahn has nothing to disclose.
Patrick Kesslak No disclosure on file
Kevin O'Dell No disclosure on file
Marcia Bandini No disclosure on file
Giuseppe Citerio No disclosure on file
Chijindu Iheanacho No disclosure on file
Catherine Lewis Catherine Lewis has nothing to disclose.
Christin Silos No disclosure on file
LeChauncy Woodard No disclosure on file
Whitney C. Brandon Whitney C. Brandon has received personal compensation for serving as an employee of Labcorp.
Matthew R. Chappell Matthew R. Chappell has received personal compensation for serving as an employee of Labcorp. Matthew R. Chappell has stock in Labcorp.